[
    {
        "pmid": "40817402",
        "title": "A prospective analysis to assess the multifactorial risk of childhood-onset hypertension: the ExAMIN Youth SA study.",
        "abstract": "Childhoodonset hypertension track adulthood rise globally Identifying risk factor early childhood remains epidemiological importance developing early intervention prevention strategy mitigate premature hypertension onset study explored change blood pressure predictive value individual composite baseline risk factor elevated blood pressure 4year period South African children included 767 healthy child aged 59 year baseline mean followup time four years Office blood pressure anthropometry cardiorespiratory fitness healthrelated quality life food intake urinary biomarkers measured Children stratified blood pressure status according 2017 American Academy Pediatrics guidelines Individual baseline risk factor well composite risk factor assessed predict followup blood pressure status prevalence elevated blood pressure declined 6 four years Longitudinally age HR178 p  0005 ethnicity HR0048 p  0001 socioeconomic status HR042 p  0004 sugarsweetened beverage intake HR167 p  0026 predicted elevated blood pressure four years significant result observed composite risk factor crosssectionally however factor pattern 1 socioeconomic status family history meat milk product intake indicated lower risk elevated blood pressure followup HR074 p  0042 Multiple risk factors including diet socioeconomic status contribute elevated blood pressure South African children Early multifaceted intervention targeting factor essential prevent longterm cardiovascular disease",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40817402/",
        "source_type": "Global"
    },
    {
        "pmid": "40817400",
        "title": "Association of home blood pressure with asymptomatic Stage B heart failure determined by cardiac biomarkers.",
        "abstract": "Heart failure HF guideline recommend screening nonsymptomatic Stage B HF Evidence utility home blood pressure BP risk stratification Stage B HF limited aimed examine association home BP prevalence Stage B HF risk symptomatic HF study used cohort data 14 day morning evening home BP measurements biomarker sampling cardiovascular event followup among Japanese outpatients Stage B HF defined Nterminal proBtype natriuretic peptide ≥125 pgmL andor highsensitivity cardiac troponin 22 ngL men 14 ngL women Among 3077 participant without prior cardiovascular disease including coronary artery disease symptomatic HF stroke others mean age 645 years 431 male 548 participant Stage B HF multivariable logistic model home systolic BP SBP associated Stage B HF OR 95 CI per 10 mmHg 122 113133 area curve AUC significantly improved adding home SBP model including office SBP AUC 07570763 median 50year followup Stage B HF associated higher risk HF hospitalization adjusted HR 95 CI 394 1451070 Home SBP tended associated increased risk HF hospitalization unadjusted HR 95 CI per 10 mmHg 129 097171 p  0081 association significant adjustment conclusion appropriate BP management using home BP monitoring progression HF could help prevent symptomatic HF",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40817400/",
        "source_type": "Global"
    },
    {
        "pmid": "40817127",
        "title": "Depressive symptoms and associated factors among patients with diabetes in public primary healthcare facilities in Kuwait city, 2024.",
        "abstract": "Depression affect nearly one four diabetes patient globally regional variation prevalence Previous study show nearly onethird type 2 patient screened positive depression crosssectional study conducted January March 2024 diabetic clinic three government primary healthcare center Kuwait City aimed assess prevalence depressive symptom associated factor among diabetes patients PHQ9 questionnaire administered via mobile linkQR scan either selfadministered intervieweradministered 11 59 patient exhibited depression symptom PHQ9 score  10 59 patient depressive symptom PHQ  10 81 n  48 age 40 years 66 n  39 females 64 n  38 Kuwait nationals 50 30 receiving treatment 10 years 54 n  32 comorbid hypertension 81 n  48 patient type 2 diabetes 71 n  42 last HbA1C  75 Smoking AOR  388 95 CI 1501012 insulin therapy combination oral hypoglycaemics insulin therapy AOR  281 95 CI 124637 significantly associated depression symptoms male less likely report depressive symptom AOR  035 95 CI 014086 Routine depression screening diabetes care recommended identify risk factor early reduce impact depression population",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40817127/",
        "source_type": "Global"
    },
    {
        "pmid": "40816298",
        "title": "Diagnostic and Therapeutic Consequences of Thyroid Ultrasound: A Retrospective Explorative Cohort Study using Claims Data.",
        "abstract": "Ultrasound US screening thyroid cancer nonindicated US thyroid lead detection mostly benign nodule small papillary carcinomas Although US screening thyroid cancer discouraged guidelines continues performed aimed explore effect thyroid US early diagnostic process diagnostic therapeutic procedure GermanyIn retrospective observational cohort study analysed claim data 2012 2016 patient without history thyroid disease propensity score matching sociodemographic characteristics selection symptom diagnosis e g fatigue hypertension morbidity last year patient initial TSH test thyroid US within 28 day test compared patient receiving initial TSH test early US Patients hypo hyperthyroidism diagnosed directly initial TSH excluded Thyroidspecific morbidity followup test therapeutic pathway analysedIn total 5390 patient remained group data selection matching mean age 465 year SD150 58 female Early US associated higher thyroidspecific morbidity especially regarding thyroid nodules Additionally patient observation group received thyroidrelated followup test utilization ambulatory healthcare service first year higher group especially internal medicine working general practice internal medicine nuclear medicine radiologyEarly use US associated increased thyroidspecific morbidity even excluding patient hypo hyperthyroidism initial TSH Subsequently diagnostic therapeutic procedure performed Increased morbidity may due overtesting diagnostic cascade resulting overdiagnosis overtreatment research needed estimate true number overdiagnoses",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40816298/",
        "source_type": "Global"
    },
    {
        "pmid": "40815242",
        "title": "2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.",
        "abstract": "2025 AHAACCAANPAAPAABCACCPACPMAGSAMAASPCNMAPCNASGIM Guideline Prevention Detection Evaluation Management High Blood Pressure Adults retires replaces 2017 ACCAHAAAPAABCACPMAGSAPhAASHASPCNMAPCNA Guideline Prevention Detection Evaluation Management High Blood Pressure Adults comprehensive literature search conducted December 2023 June 2024 identify clinical studies reviews evidence performed human subject published since February 2015 English MEDLINE through PubMed EMBASE Cochrane Library Agency Healthcare Research Quality selected database relevant guideline focus clinical practice guideline create living working document updating current knowledge field high blood pressure aimed practicing primary care specialty clinician manage patient hypertension",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40815242/",
        "source_type": "Global"
    },
    {
        "pmid": "40814414",
        "title": "Effect of Home-based Mobile Guided Pranayam and Yog Nidra Meditation on Blood Pressure and Sleep Quality of Elderly Hypertensive Individuals: A Randomised Controlled Trial.",
        "abstract": "Elderly vulnerable population increased risk hypertensionrelated cardiovascular mortality Yog involving various asan pranayam meditation shown decrease blood pressure adults study involving elderly participants practicing pranayam meditation home mobile guided system lacking study efficacy homebased mobileguided pranayam meditation management hypertension elderly present study carried India Institute Medical Sciences Rishikesh Trial started registration Clinical trial registration India httpswwwctrinicin CTRI number  CTRI202103031631 105 eligible participant allocated two arm ratio 11 Control arm provided standard treatment pharmacological nonpharmacological per 2017 AHAACC guideline hypertension 24 weeks intervention arm given standard treatment along mobileguided pranayam yog nidra meditation home 24 weeks Systolic blood pressure SBP diastolic blood pressure DBP sleep quality assessed baseline 24 week followup 24 weeks intervention group exhibited statistically significant reduction SBP decrease 47 mmHg compared control arm Additionally intervention arm reported significant improvement sleep quality Study result indicate homebased mobileguided pranayam yog nidra meditation valuable adjunct standard hypertension treatment elderly individuals lowering blood pressure also enhancing sleep quality",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814414/",
        "source_type": "Global"
    },
    {
        "pmid": "40814082",
        "title": "Real-world analysis of characteristics and guideline adherence of antiplatelet drugs prescriptions among patients with coronary artery disease and its comorbidities: a cross-sectional study.",
        "abstract": "identify characteristic antiplatelet drug APD prescription based regional largescale outpatient database Shanghai China compare practical usage APDs respective clinical guideline patient coronary artery disease CAD China Outpatient electronic healthcare record extracted 20 medical institution Shanghai January 2020 October 2021 Outpatient APD prescription among CAD patient comorbidity status analyzed χsup2sup test guideline adherence specific APD regimen also evaluated 1532972 outpatient visits 284400 1855 involved APDs APD likely utilized patient recent ACS 2760 χsup2sup  888475 P  0001 CCS n  280025 1846 χsup2sup  881045 P  0001 coexisting hyperlipidemia n  22387 2907 χsup2sup  5938871 P  0001 diabetes n  14087 2292 χsup2sup  808226 P  0001 hypertension n  40193 2211 χsup2sup  1724758 P  0001 atherosclerosis n  439 2124 χsup2sup  9885 P  0002 Recent ACS patient CCS patient comorbidities prone treated dual aspirinclopidogrel therapy P  0001 Dual aspirinticagrelor therapy second common choice CCS patient n  210230 1386 χsup2sup  9274 P  0002 followed aspirin n  203551 1342 χsup2sup  59267 P  0001 clopidogrel n  75702 499 χsup2sup  4276533 P  0001 ticagrelor monotherapy n  794 052 χsup2sup  4276533 P  0001 Among recent ACS patients clopidogrel monotherapy second frequently used n  2624 1650 χsup2sup  4304044 P  0001 followed dual aspirinticagrelor therapy n  2071 1303 χsup2sup  9101 P  0003 aspirin monotherapy n  1082 1133 χsup2sup  58818 P  0001 ticagrelor monotherapy n  354 223 χsup2sup  84768 P  0001 rationality analysis showed CCS rating 3 representing average recent ACS CAD reflux esophagitis APD prescription consistent guideline rating  2 proportion APD prescription CAD outpatient lower expected rationality analysis revealed CCS recent ACS patient showed suboptimal guideline adherence realworld APD prescriptions especially patient comorbid reflux esophagitis gap indicated realworld prescription activity disease receive attention",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814082/",
        "source_type": "Global"
    },
    {
        "pmid": "40814058",
        "title": "The association between dietary obesity-prevention score and cardiovascular risk factors.",
        "abstract": "Dietary Obesity Prevention Score DOS dietary assessment tool previously linked obesity study aimed explore association DOS selected cardiovascular disease CVD risk factors crosssectional analysis conducted among 1332 adult employee Tehran University Medical Sciences Dietary intake assessed using validated food frequency questionnaire FFQ DOS calculated based established criteria Serum level total cholesterol lowdensity lipoprotein cholesterol LDLC highdensity lipoprotein cholesterol HDLC triglyceride TG blood sugar BS level measured using standard commercial kits Binary logistic regression model used examine association DOS CVD risk factors Tehran University Medical Sciences One thousand three hundred thirtytwo adult university employees mean age body mass index BMI participant 428 year 272 kgmsup2sup respectively adjusting potential confounders individual highest DOS quintile 47 lower odds hypertension compared lowest quintile OR 053 95 CI 030094 P  0006 marginally significant inverse association also observed low HDLC OR 060 95 CI 038095 P  005 significant association found DOS CVD risk factors Higher adherence Dietary Obesity Prevention Score may linked lower odds hypertension low HDLC research warranted confirm findings",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814058/",
        "source_type": "Global"
    },
    {
        "pmid": "40814000",
        "title": "Deep phenotyping of a modified diabetic cardiomyopathy mouse model which reflects clinical disease progression.",
        "abstract": "Diabetic cardiomyopathy DbCM progressive disease common complication metabolic diabetes characterised onset cardiac structural functional impairment lead direct development clinical heart failure HF predispose hypertensiveischaemic stress DbCM complex disease involves several metabolic pathogenic factors characterised established highfat dietstreptozotocin HFDSTZinduced DbCM model incorporating typical feature human disease determine suitability preclinical evaluation novel therapeutic prior advancement human trials Male C57BL6J mouse randomised HFD singledose STZ 100 mgkg control diet CD vehicle HFDSTZ mouse developed type 2 diabetes mellitus T2DM reflected high fasting blood glucose HbA1c levels reduced βcell function increased insulin resistance without systolic blood pressure alteration Furthermore HFDSTZ mouse displayed progressive diastolic dysfunction evidenced decreased MV EA ratio together elevated chronic left ventricular LV filling pressure parameters measured left atrial LA area LA volume compared controls parallel LV hypertrophy fibrosis Monocyte trafficking diabetic heart identified singlenuclei RNA sequencing analysis revealed interferonα response DbCM mice whilst plasma proteomics confirmed involvement inflammatory process elevated plasma Creactive protein DbCM progression Taken together HFDSTZinduced DbCM model exhibit unique DbCM preclinical phenotype reflecting triplehit human DbCM feature comprising 1 T2DM insulin resistance 2 progressive diastolic dysfunction LV remodelling 3 metabolic inflammation improved HFDSTZinduced DbCM model support clinically relevant research DbCM progression early stage cardiac dysfunction remodelling basis translational investigation",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814000/",
        "source_type": "Global"
    },
    {
        "pmid": "40813924",
        "title": "Hypertension in 2025: are we ready for bold precision public health approaches worldwide?",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40813924/",
        "source_type": "Global"
    },
    {
        "pmid": "40813684",
        "title": "Carotenoid and peptide supplementation from Caulerpa sp. (sea grapes) extract mitigate metabolic syndrome in cholesterol-enriched diet rats via modulation of gut microbiota.",
        "abstract": "Metabolic syndrome MetS multifactorial disorder characterized obesity dyslipidemia insulin resistance hypertension increasing risk cardiovascular disease type 2 diabetes mellitus T2DM Recent evidence suggests gut microbiome dysbiosis play significant role MetS pathogenesis Functional food enriched bioactive compounds particularly derived marine sources emerged promising interventions study aimed evaluate effect carotenoid peptide supplementation iCaulerpa spi sea grapes extract metabolic syndrome gut microbiome modulation cholesterolfatenriched diet CFED rats randomized preclinical trial conducted using CFEDfed rats supplemented carotenoid peptide extract iCaulerpa spi Metabolic parameters lipid profiles enzymatic activities inflammatory biomarkers assessed Additionally gut microbiota composition analyzed using highthroughput sequencing techniques Supplementation iCaulerpa spi extract significantly improved metabolic markers including reduction body weight gain triglycerides total cholesterol lowdensity lipoprotein LDL blood glucose levels increasing highdensity lipoprotein HDL ipi  005 Enzymatic analysis revealed suppression key metabolic enzymes αglucosidase lipase suggesting potential regulatory effect lipid carbohydrate metabolism Moreover gut microbiome analysis indicated increased microbial diversity favorable shift bacterial taxa Specifically iFaecalibacteriumi iLactobacillusi known antiinflammatory metabolic benefits enriched iOscillospirai associated metabolic disorders showed decline microbial change suggest potential role iCaulerpa spi modulating gut health systemic metabolism finding demonstrate carotenoid peptide extract iCaulerpa spi effectively mitigate metabolic syndrome metabolic regulation gut microbiome modulation antiinflammatory mechanisms study highlight iCaulerpa spi potential functional food MetS management paving way future clinical applications applicable Image see text",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40813684/",
        "source_type": "Global"
    },
    {
        "pmid": "40813611",
        "title": "Small intestinal bacterial overgrowth as one of the diagnostic markers of hypertension.",
        "abstract": "High blood pressure one leading cause premature death worldwide previous study found washed microbiota transplantation significant antihypertensive effect patient hypertension retrospective study designed assess association small intestinal bacterial overgrowth SIBO hypertension primary intestinal disease excluded methane hydrogen breath test used diagnose intestinal bacterial overgrowth positive rate SIBO compared hypertensive nonhypertensive groups risk SIBO occurrence various related factor analyzed comprehensively excluding secondary hypertension compare prevalence hypertension SIBO  SIBO  groups Finally risk degree occurrence development hypertension analyzed comprehensively excluding primary intestinal disease 263 patient hypertension 480 patient without hypertension enrolled positive rate SIBO hypertensive patient significantly higher nonhypertensive patient 4900 vs 3750 P  0002 Logistic regression adjusted confounding factors hypertension risk factor positive SIBO OR  1478 95 CI 10392102 P  003 Excluding secondary hypertension 333 patient SIBO  group 454 patient SIBO  group included prevalence hypertension SIBO  patient significantly higher SIBO  patient 4110 vs 3150 P  0005 positive rate SIBO hypertensive patient higher nonhypertensive patients prevalence hypertension patient positive SIBO higher patient negative SIBO SIBO closely related hypertension one diagnostic marker hypertension",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40813611/",
        "source_type": "Global"
    },
    {
        "pmid": "40813129",
        "title": "Cardiovascular, kidney related, and weight loss effects of therapeutics for type 2 diabetes: a living clinical practice guideline.",
        "abstract": "benefit harm medication adult type 2 diabetes varied risk cardiovascular kidney related complications Emerging clinical trial novel medication demonstrated benefit cardiovascular kidney weight related outcome people type 2 diabetes Dynamically updated practice guideline adhering standard trustworthiness necessary response rapidly evolving evidence base availability multiple medication alternatives living practice guideline incorporates latest available medication evidence provides recommendation stratified risk cardiovascular kidney complication inform diabetes management panel issued riskstratified recommendation regarding four prioritised medication adult type 2 diabetes SGLT2 inhibitors GLP1 receptor agonists finerenone tirzepatide• Lower risk three fewer cardiovascular risk factor without established cardiovascular disease CVD chronic kidney disease CKD weak recommendation SGLT2 inhibitor GLP1 receptor agonists• Moderate risk more three cardiovascular risk factor without established CVD CKD established CVD andor CKD lower risk complications weak recommendation favour SGLT2 inhibitor GLP1 receptor agonists weak recommendation finerenone adult CKD• Higher risk established CVD andor CKD higher risk complications established heart failure strong recommendation favour SGLT2 inhibitor GLP1 receptor agonists weak recommendation favour finerenone adult CKD• Across risk strata weak recommendation favour tirzepatide adult obesity international panel including two patient partners clinicians methodologists produced recommendations panel followed standard trustworthy guideline used GRADE approach explicitly considering balance benefits harm burden treatment individual patient perspective Recommendations informed linked living systematic review network metaanalysis evaluating relative benefit harm updated 31 July 2024 linked systematic review addressing risk prediction model value preference adult type 2 diabetes Candidate therapeutic prioritised based availability sufficient randomised trial data relevance global audience likelihood changing practiceThis first version living guideline guideline part iBMJ Rapid Recommendationsi series MAGICapp display recent version guideline full content including evidence summary decision aids major update published iThe BMJi encourage reuse adaptation translation living guidelines recognise lack availability high cost medication may prohibitive impact recommendation implemented across different health care systems",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40813129/",
        "source_type": "Global"
    },
    {
        "pmid": "40813122",
        "title": "Medications for adults with type 2 diabetes: a living systematic review and network meta-analysis.",
        "abstract": "provide uptodate evidence key benefits harms uncertainty regarding medication adult type 2 diabetes Living systematic review network metaanalysis NMA using frequentist random effect GRADE grading recommendations assessment development evaluation approaches Updates planned least two time year Medline Embase searched 31 July 2024 current iteration Randomised controlled trial least 24 week comparing one medication standard treatment placebo other systematic review NMA includes 493 168 participant 869 trial adding 53 trial since October 2022 reporting data 13 drug class 63 drugs 26 outcome interest Regarding benefits moderate high certainty evidence confirms well established cardiovascular kidney benefit sodiumglucose cotransporter2 SGLT2 inhibitors glucagonlike peptide1 receptor agonist GLP1RAs finerenone the last patient established chronic kidney disease effective drug reducing body weight tirzepatide mean difference MD 863 kg 95 confidence interval 934 793 moderate certainty orforglipron MD 787 kg 1024 550 low certainty followed eight GLP1RAs high moderate certainty Absolute benefit medication vary substantially depending baseline risk cardiovascular kidney outcomes riskstratified absolute effect medication summarised using interactive multiple comparison tool httpsmatchitmagicevidenceorg250709distdiabetes Regarding medicationspecific harms SGLT2 inhibitor increase genital infection odds ratio OR 329 95 CI 288 377 high certainty ketoacidosis due diabetes OR 208 145 299 high certainty probably increase amputation OR 127 101 161 moderate certainty tirzepatide GLP1RAs probably increase severe gastrointestinal event most increased risk tirzepatide OR 421 187 949 moderate certainty finerenone increase severe hyperkalaemia OR 592 302 1162 high certainty thiazolidinediones increase major osteoporotic fracture probably increase hospitalisation heart failure Sulfonylureas insulin dipeptidyl peptidase4 inhibitor probably increase risk severe hypoglycaemia low low certainty evidence effect diabetesrelated complications including neuropathy visual impairment Despite interest issue uncertainty whether GLP1RAs may reduce dementia OR 092 083 102 low certainty living systematic review provides comprehensive summary cardiovascular kidney weight loss benefits well medicationspecific harm medication adult type 2 diabetes including effect SGLT2 inhibitors GLP1RAs finerenone tirzepatide PROSPERO number CRD42022325948 detailed protocol available httpsdataaliveevidenceorgrecordsq02rvkm486 article first version living systematic review linked living iBMJi Rapid Recommendation living clinical practice guidelines presenting risk stratified recommendation patient type 2 diabetes lower moderate higher risk cardiovascular kidney complications latest evidence made available via iBMJi Rapid Recommendation via interactive GRADE evidence summary MATCHIT httpsmatchitmagicevidenceorg250709distdiabetes Major update published iThe BMJi",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40813122/",
        "source_type": "Global"
    },
    {
        "pmid": "40812793",
        "title": "Cyclosporine in uveitis: a game changer or a risky choice? A systematic review and meta-analysis of its efficacy and safety.",
        "abstract": "Uveitis inflammation uveal tract lead severe ocular complication vision loss left untreated Cyclosporine gained recognition effective immunosuppressive therapy particularly steroidsparing agent study aim evaluate efficacy safety cyclosporine managing various type uveitis assess safety profile associated adverse effects compare therapeutic effectiveness treatment options Systematic review metaanalysis conducted PubMed Science Direct Dimensions Google Scholar database 7 February 2025 Preferred Reporting Items Systematic Reviews MetaAnalyses guideline followed Population Intervention Comparison Outcomes Study Design framework observed inclusion criteria Eligible study included randomised controlled trials cohort study case series assessed cyclosporine use form uveitis Outcomes included improvement visual acuity inflammation control remission rate adverse event nephrotoxicity hypertension fatigue Risk bias assessed using Cochrane RoB 2 tool Randomized Control Trials Risk Bias NonRandomized Interventional study nonrandomised studies Quality evaluated using Joanna Briggs Institute Critical Appraisal Checklist casecontrol study case series study evaluation NewcastleOttawa Scale cohort studies total 57 703 study identified database searching removal duplicate application inclusion exclusion criteria 16 study encompassing 943 patient included final analysis metaanalysis demonstrated cyclosporine therapy resulted significant visual acuity improvement stabilisation approximately 79 patient event rate0879 95 CI 0832 0914 p00001 I²0 reflecting robust consistent therapeutic benefit Control intraocular inflammation achieved approximately 77 patient event rate0767 95 CI 0705 0818 p00001 I²0 underscoring cyclosporines efficacy managing inflammatory activity However complete disease remission achieved 43 patient event rate043 95 CI 039 048 p0044 indicating cyclosporine effectively control disease activity consistently induce longterm remission Adverse effect common clinically significant Fatigue frequently reported adverse event affecting approximately 65 patients Nephrotoxicity indicated elevated serum creatinine observed 57 patients highlighting critical need regular renal monitoring therapy Hypertension developed 21 patients necessitating periodic blood pressure assessment Importantly heterogeneity across study major outcome negligible I²0 publication bias assessed minimal lending credibility pooled estimates Cyclosporine demonstrates significant efficacy management noninfectious uveitis improving visual acuity approximately 79 patient achieving inflammation control 77 However complete remission attained 43 cases Adverse events notably nephrotoxicity 57 hypertension 21 frequent highlight need careful monitoring finding affirm cyclosporines role effective steroidsparing immunosuppressive agent vision preservation though longterm use requires individualised riskbenefit evaluation CRD42025644344",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40812793/",
        "source_type": "Global"
    },
    {
        "pmid": "40812624",
        "title": "Pregnancy outcomes in women with the highest cardiovascular risk (mWHO class IV): A single-centre study.",
        "abstract": "modified World Health Organization mWHO classification maternal risk used estimate morbidity mortality pregnant woman cardiovascular disease Despite guideline advising pregnancy highest risk category mWHO Class IV successful outcome achieved select managed case specialised multidisciplinary care singlecentre study examines pregnancy outcome highrisk group conducted retrospective cohort study 32 pregnancy 30 woman classified mWHO Class IV 2008 2022 Maternal demographics cardiac obstetric complications delivery details neonatal outcomes longterm followup data collected analysed mean maternal age delivery 296 ± 51 years Pulmonary arterial hypertension PAH systemic ventricular dysfunction prevalent conditions Cardiovascular event occurred 656  pregnancies PAH accounting majority woman delivered via Caesarean section 937  general anaesthesia Preterm birth occurred 75  cases 87  neonate required NICU admission One maternal death occurred late postpartum period one year major adverse cardiovascular event MACE rate 93  Longterm followup revealed three additional maternal deaths Although pregnancy woman mWHO Class IV disease carry substantial risk favourable outcome achievable tertiary centre specialised Pregnancy Heart Team  However burden morbidity remains high reinforcing need early counselling close surveillance longterm followup vulnerable population",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40812624/",
        "source_type": "Global"
    },
    {
        "pmid": "40811877",
        "title": "Low-Level Environmental Metals Exposures, Biomarkers of Myocardial Injury and Hemodynamic Stress, and Mortality Risk.",
        "abstract": "exact pathophysiologic mechanism environmental toxic metal particularly lead cadmiumassociated cardiovascular event remains poorly understood author assessed impact lead cadmium myocardial injury stress explored role risk allcause cardiovascular mortality included participant studied measurement National Health Nutrition Examination Survey 1999 2004 followed 2019 Generalized linear regression applied examine association whole blood lead cadmium cardiacspecific biomarkers inflammation oxidative stress potential pathway underpinning association mortality explored using mediation analyses total 11193 participant included nearly 939 individual lead level World Health Organization guideline clinical management lead 5 μgdL Lead cadmium level positively associated metric myocardial injury highsensitivity troponin I myocardial stress Nterminal prohormone Btype natriuretic peptide NTproBNP inflammation oxidative stress Creactive protein total homocysteine methylmalonic acid mortality risks Significant increase 223 highsensitivity troponin 705 NTproBNP associated per SD increase lead levels higher troponin NTproBNP level may mediate 3310 association cardiovascular mortality lead cadmium association greater older participant diabetes hypertension result suggest association lowlevel lead cadmium exposure mortality risk may potentially mediated worsening myocardial injury stress",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40811877/",
        "source_type": "Global"
    },
    {
        "pmid": "40811516",
        "title": "2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.",
        "abstract": "2025 AHAACCAANPAAPAABCACCPACPMAGSAMAASPCNMAPCNASGIM Guideline Prevention Detection Evaluation Management High Blood Pressure Adults retires replaces 2017 ACCAHAAAPAABCACPMAGSAPhAASHASPCNMAPCNA Guideline Prevention Detection Evaluation Management High Blood Pressure Adults comprehensive literature search conducted December 2023 June 2024 identify clinical studies reviews evidence performed human subject published since February 2015 English MEDLINE through PubMed EMBASE Cochrane Library Agency Healthcare Research Quality selected database relevant guideline focus clinical practice guideline create living working document updating current knowledge field high blood pressure aimed practicing primary care specialty clinician manage patient hypertension",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40811516/",
        "source_type": "Global"
    },
    {
        "pmid": "40811497",
        "title": "2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.",
        "abstract": "2025 AHAACCAANPAAPAABCACCPACPMAGSAMAASPCNMAPCNASGIM Guideline Prevention Detection Evaluation Management High Blood Pressure Adults retires replaces 2017 ACCAHAAAPAABCACPMAGSAPhAASHASPCNMAPCNA Guideline Prevention Detection Evaluation Management High Blood Pressure Adults comprehensive literature search conducted December 2023 June 2024 identify clinical studies reviews evidence performed human subject published since February 2015 English MEDLINE through PubMed EMBASE Cochrane Library Agency Healthcare Research Quality selected database relevant guideline focus clinical practice guideline create living working document updating current knowledge field high blood pressure aimed practicing primary care specialty clinician manage patient hypertension",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40811497/",
        "source_type": "Global"
    },
    {
        "pmid": "40811494",
        "title": "A Trans-Atlantic Perspective on the 2025 AHA/ACC Guidelines for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40811494/",
        "source_type": "Global"
    },
    {
        "pmid": "40810544",
        "title": "General practitioners' perspectives, preferences, and practices in prescribing antihypertensive medication in primary, uncomplicated hypertension.",
        "abstract": "International guideline consider antihypertensive medication AHM class equivalent option treating primary hypertension However limited research examined whether general practitioner GPs share view specific prescribing preferences Understanding GPs perspective crucial identifying guideline implemented daily practice study explores perspectives preferences prescribing practice Dutch GPs regarding AHM class patient primary hypertension cardiovascular comorbidities diabetes conducted qualitative study semistructured interview among Dutch GPs Interviews audiorecorded transcribed verbatim thematically analyzed interviewed 18 Dutch GPs 56 female identified three key themes contextual factor initiating treatment preference AHM classes consideration combination therapy GPs consider lifestyle modifications patient age initial blood pressure BP deciding treatment GPs view AHM class interchangeable preference shaped perceived efficacy side effects patientspecific factors including ethnicity patient preferences GPs often favour gradual titration approach starting one class adjusting dosage adding another GPs adopt multifaceted patientcentred approach hypertension prioritizing lifestyle intervention weighing shortterm risk longterm benefits identified several discrepancy guideline recommendation everyday practiceparticularly regarding perceived nonequivalence AHM class limited support initiating combination therapy Incorporating GPs perspective guideline development may lead practical tailored recommendation improve adherence patient outcome realworld care",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40810544/",
        "source_type": "Global"
    },
    {
        "pmid": "40810037",
        "title": "Use of Gabapentin for Paroxysmal Sympathetic Hyperactivity in Three Children with Severe Motor and Intellectual Disability due to Neonatal Hypoxic Ischemic Encephalopathy.",
        "abstract": "Paroxysmal sympathetic hyperactivity PSH clinical syndrome characterized recurrent episode sympathetic overactivity including hypertonia tachycardia hypertension hyperthermia typically following severe brain injury PSH well documented adult populations report pediatric patients particularly severe motor intellectual disability SMID remain limited Here report three pediatric patient SMID due neonatal hypoxicischemic encephalopathy NHIE developed PSH patient presented characteristic PSH symptom diagnosed according Pediatric Clinical Practice Guidelines based 2014 consensus criteria Gabapentin GBP initiated low dos 510 mgkgday patients resulting rapid resolution PSH symptoms two patients symptom partially recurred within several month controlled GBP dose adjustment addition clonidine agents severe adverse event observed knowledge first report describing shortterm efficacy GBP pediatric patient developed PSH SMID status due NHIE finding suggest GBP valuable welltolerated therapeutic option management PSH child conditions",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40810037/",
        "source_type": "Global"
    },
    {
        "pmid": "40809729",
        "title": "Safety and Sufficient Cardiac Rehabilitation With a Wearable Activity Tracker in a Patient With Acute Myocardial Infarction and Residual Stenosis.",
        "abstract": "Guidelines recommend exercisebased cardiac rehabilitation CR 2  3 time per week However high number visit per week outpatient CR burden lower patient compliance Homebased exercise key patient perform sufficient volume exercise sometimes need careful patient coronary artery stenosis Wearable activity tracker would useful maintaining appropriate intensity sufficient volume homebased exercise 65yearold male patient unremarkable past medical history chest pain visited hospital primary diagnosis acute myocardial infarction culprit lesion 99 stenosis posterior descending artery left circumflex artery successfully treated also diagnosed obesity hypertension diabetes mellitus dyslipidemia residual 75 stenosis left anterior descending artery started pharmacotherapy planned elective percutaneous coronary intervention 5 months required exercisebased CR discharge Outpatient CR scheduled week needed additional homebased exercise used wearable activity tracker iAide2W TOKAI Corp Gifu Japan check appropriate intensity exercise maintain sufficient volume homebased exercise device able monitor metabolic equivalent acceleration sensor telemetry could check intensity exercise specialized online site Thanks device able reduce body weight increase exercise tolerance without chest pain percent predicted oxygen intake per body weight increased 84 95 anaerobic threshold 68 83 peak 5 months treated residual stenosis successfully Wearable activity tracker used evaluate biological information daily life expected useful CR",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40809729/",
        "source_type": "Global"
    },
    {
        "pmid": "40807125",
        "title": "A Narrative Review of the Clinical Applications of Echocardiography in Right Heart Failure.",
        "abstract": "bBackgroundObjectivesb Historically echocardiographic imaging right heart challenging abnormal geometry conducive reproducible anatomical functional assessment development advanced echocardiographic techniques possible complete integrated assessment right heart fewer assumptions resulting increased accuracy precision Echocardiography continues firstline imaging modality diagnostic analysis management acute chronic right heart failure portability versatility affordability compared cardiac computed tomography magnetic resonance imaging nuclear scintigraphy positron emission tomography Virtually echocardiographic parameter wellvalidated demonstrated prognostic significance goal narrative review echocardiographic parameter right heart chamber hemodynamic alteration associated right ventricular dysfunction present information must acquired examination deliver comprehensive assessment right heart discus clinical significance right heart failure bMethodsb Using literature search PubMed database 1985 2025 Cochrane database included limited terminology descriptive right heart anatomy function disease state involving acute chronic right heart failure pulmonary hypertension application conventional advanced echocardiographic modality strive elucidate pathophysiology right heart failure reviewed randomized control trials observational retrospective prospective cohort studies societal guidelines systematic review articles bConclusionsb addition conventional 2dimensional echocardiography color spectral tissue Doppler measurements contemporary echocardiographic assessment patient suspected proven right heart failure must include 3dimensional echocardiographicderived measurements speckletracking echocardiography strain analysis hemodynamics parameter characterize right heart anatomy also determine underlying pathophysiology right heart failure Complete pointofcare echocardiography available virtually clinical setting routine care imaging tool particularly indispensable emergency department intensive care units operating room provide immediate assessment right ventricular function associated hemodynamic change assist realtime management decisions",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40807125/",
        "source_type": "Global"
    },
    {
        "pmid": "40805996",
        "title": "Trends in Urinary Sodium-to-Potassium Ratios in Koreans: Analysis of KNHANES 2016-2023 Data.",
        "abstract": "bBackgroundObjectivesb Recent Japanese guideline recommend using average sodiumtopotassium NaK ratio casual urine sample assess hypertension cardiovascular risk suggesting cutoff 2 optimal 4 feasible aimed evaluate proportion Korean individual would classified elevated NaK ratio using cutoffs based random urine NaK measurement obtained nationally representative Korea National Health Nutrition Examination Survey KNHANES dataset bMethodsb analyzed 50440 participant KNHANES 20162023 available random urine Na K results Annual urinary NaK ratio calculated prevalence ratio ≥2 ≥4 assessed age sex using sampling weights bResultsb weighted median NaK ratio consistently lower weighted means indicating skewed distributions 2016 2023 weighted median mean value increased 23 27 28 33 respectively prevalence NaK ratio ≥2 increased 605 720 ratio ≥4 increased 169 283 Ushaped trend NaK ≥4 prevalence observed age highest among 20 ≥70 years Males higher prevalence female age group except 2029 bConclusionsb growing proportion Koreans exceeded NaK cutoff 2 4 time Age sexspecific variation suggests tailored interpretation may necessary applying threshold population health monitoring",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40805996/",
        "source_type": "Global"
    },
    {
        "pmid": "40805116",
        "title": "Cardiotoxicity in Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia.",
        "abstract": "incidence cardiac morbimortality patient relapsedrefractory RR acute myeloid leukemia AML unknown analyze characteristics incidence risk factors outcome cardiac event AML patient treated secondline 2L thirdline 3L episodes Among 327 2L AML patient median age 62 year old 135 experienced cardiac events incidence 386 nonfatal 13 fatal event 6 months grade 12 incidence 168 grade 34 incidence 235 6 months Overall 207 cardiac event occurred 2L cohort frequent hypertension n  45 bradycardia n  39 QTc prolongation n  35 heart failure n  33 syncopepresyncope n  22 arrhythmia n  18 myocardial ischemia n  8 Median OS 2L cohort 94 months 214 month patient grade 12 88 month patient without cardiac event 76 month grade 34 patients 21 month 5 patient ipi  00035 multivariate analysis showed prior cardiologic antecedent ipi  0013 intensive 2L chemotherapy ipi  001 inclusion 2L clinical trial ipi  0001 independent risk factor nonfatal cardiac events Among 189 patient 3L cohort incidence nonfatal fatal cardiac event 492 0 6 months respectively Nonfatal cardiac event frequent patient prior cardiac antecedent ipi  0004 summary cardiotoxicity frequent challenging complication RR AML patients identified risk factor could relevant implementing riskadapted management guidelines aiming reduce morbimortality difficulttotreat setting",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40805116/",
        "source_type": "Global"
    },
    {
        "pmid": "40804505",
        "title": "Consensus on acromegaly therapeutic outcomes: an update.",
        "abstract": "15th Acromegaly Consensus Conference September 2023 updated recommendation therapeutic outcome acromegaly Since publication medical management guideline 2018 new pharmacological agent new treatment approach developed Fiftytwo expert management acromegaly reviewed current literature assessed change drug approvals clinical practice standard management Current outcome goal considered focus effect current emerging somatostatin receptor ligands growth hormone receptor antagonist pegvisomant dopamine agonist cabergoline biochemical control clinical control adenoma mass surgical outcomes Participants assessed factor determine pharmacological choices well proposed use agent Here present consensus recommendation highlighting evidencebased acromegaly management algorithm could optimized clinical practice",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40804505/",
        "source_type": "Global"
    },
    {
        "pmid": "40804225",
        "title": "Comparative Effect of Roux-en-Y Gastric Bypass vs. One-Anastomosis Gastric Bypass for Revisional Surgery After Sleeve Gastrectomy With Insufficient Clinical Response: A Systematic Review and Meta-analysis.",
        "abstract": "Sleeve gastrectomy SG performed bariatric procedure worldwide Although effective short term high insufficient clinical response rate leading weight regain gastroesophageal reflux disease GERD necessitating revisional surgery two primary option conversion procedure RouxenY gastric bypass RYGB considered gold standard oneanastomosis gastric bypass OAGB recognized simplicity metabolic benefits compare effectiveness safety RYGB OAGB revisional procedure insufficient clinical response SG term weight loss metabolic improvements surgical complications operative time systematic review metaanalysis followed PRISMA guidelines comprehensive search conducted across six database PubMed Scopus Web Science Cochrane OvidMedline Embase 236 identified studies five met inclusion criteria Data analyzed using relative risk RR categorical variable mean difference MD continuous outcomes applying randomeffects model OAGB showed statistically significant advantage total weight loss percentage TWL compared RYGB MD  124 95 CI  194  053 p  00006 However significant difference observed BMI reduction MD 000 95 CI  124 124 p  100 technique demonstrated similar remission rate hypertension RR 085 95 CI 060122 p  038 GERD RR 100 95 CI 086117 p  097 type 2 diabetes RR 097 95 CI 079121 p  081 Postoperative complication comparable group RR 089 95 CI 067118 p  042 However operative time significantly shorter OAGB MD 3010 min 95 CI 2789 3232 p  000001 OAGB demonstrated greater total weight loss shorter operative time compared RYGB comparable safety profile technique equally effective managing hypertension GERD though OAGB showed nonsignificant trend favoring type 2 diabetes remission RYGB may preferable patient severe GERD highquality longterm study needed establish optimal revisional procedure SG",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40804225/",
        "source_type": "Global"
    },
    {
        "pmid": "40804214",
        "title": "Rethinking lumbar puncture safety: pathophysiology, diagnostic uncertainty, and research gaps in herniation risk.",
        "abstract": "Lumbar puncture LP key diagnostic therapeutic tool yet concern persist potential induce brain herniation especially patient elevated intracranial pressure ICP Despite ongoing debate precise risk factor pathophysiological mechanism remain unclear systematic review aim examine risk cerebellar paradoxical brain herniation following LP evaluate current evidence regarding incidence discus implication clinical practice well show gap research Following PRISMA guidelines systematic literature review conducted using PubMed MEDLINE database Studies 1990 2024 focusing bacterial meningitis idiopathic intracranial hypertension postsurgical states condition associated elevated ICP included LPrelated herniation reported diverse clinical settings cerebellar herniation primarily seen bacterial meningitis idiopathic intracranial hypertension Herniation onset varied minute day postLP cranial CT widely used risk assessment predictive accuracy debated Although LP relatively safe herniation risk highly contextdependent Clinicians integrate clinical radiological pathophysiological factor decisionmaking research needed refine predictive model establish evidencebased guideline highrisk patients",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40804214/",
        "source_type": "Global"
    },
    {
        "pmid": "40804167",
        "title": "Primary aldosteronism and long-term outcomes using PAMO definition.",
        "abstract": "Primary aldosteronism common form endocrine hypertension traditionally managed unilateral adrenalectomy unilateral disease medical therapy bilateral forms However mineralocorticoid receptor antagonist often poorly tolerated less effective preventing cardiovascular outcomes international retrospective cohort study evaluated clinical biochemical outcome adrenal surgery 56 patient bilateral primary aldosteronism six referral center across five countries Patients underwent either unilateral n  43 bilateral n  13 adrenal surgery based adrenal venous sampling CT findings 612 month followup clinical benefit observed 81 patient unilateral surgery 92 bilateral surgery Biochemical success achieved 65 85 groups respectively Similar benefit persisted beyond 12 months Adrenal insufficiency occurred 31 patient bilateral surgery transient cases Histopathological analysis revealed bilaterally symmetric aldosteroneproducing lesion majority patient undergoing bilateral adrenalectomy including adenomas micronodules diffuse hyperplasia finding suggest adrenal surgery including selected bilateral disease result favorable clinical biochemical outcome acceptable safety profile challenging prevailing paradigm exclusive medical management bilateral primary aldosteronism",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40804167/",
        "source_type": "Global"
    },
    {
        "pmid": "40804081",
        "title": "Nationwide study of spondyloarthritis spectrum and disease characteristics in Egypt.",
        "abstract": "aim study describe array disease characteristic spondyloarthritis SpA across Egypt work included 1401 SpA patient recruited 15 specialized Egyptian rheumatology center representing 20 major cities demographic clinical features well therapeutic data recorded mean age patient 376 ± 114 years disease duration 801 ± 67 years age onset 299 ± 11 years 148 106 juvenileonset 813 male 588 female M F 141 57 diabetic 61 hypertensive 193 smokers mean BASDAI 398 ± 178 BASFI 402 ± 177 human leukocytic antigen HLAB27 positive 198 Biologic therapy received 555 followed methotrexate 36 steroids 108 sulfasalazine 107 males age onset significantly lower p  002 radiographic axSpA neuropsychiatric pulmonary manifestations HLAB27 positivity receiving biologic therapy significantly higher p  002 p  00001 p  003 p  00001 p  00001 females cutaneous manifestation arthritis significantly frequent p  00001 p  00001 positive HLAB27 significantly higher frequency 73 p  0003 male gender 662 p  00001 longer disease duration p  0001 receiving higher frequency biologic therapy 89 p  00001 Radiographic axial SpA reported Assuit 159 nraxSpA Cairo 245 peripheral arthritis Giza 307 unclassified Kafr ElSheikh 339 p  0002 spectrum SpA Egypt inconsistent across country Gender disease subtype HLAB27 seem play key role phenotypic presentation",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40804081/",
        "source_type": "Global"
    },
    {
        "pmid": "40803758",
        "title": "Renal Denervation in Hypertension and Chronic Heart Failure.",
        "abstract": "Renal denervation RDN interventional approach target sympathetic nervous system goal modulating activity important contributor pathogenesis many cardiovascular metabolic diseases Unlike pharmacologic therapies RDN efficacy independent patient adherence medications remains major limiting factor longterm blood pressure control Initially developed treat severe treatmentresistant hypertension RDN demonstrated consistent result recent shamcontrolled trial across spectrum hypertension result RDN incorporated European guideline treatment option select patient endorsed cardiovascular hypertension society worldwide review outline physiological rationale behind RDN summarizes current evidence supporting effectiveness provides overview available technologies evaluates emerging role treatment chronic heart failure condition characterized high sympathetic nervous system activity Finally author explore future directions including concept multiorgan denervation aim achieve enhanced degree sympathetic modulation targeting additional sympathetic nerve beyond kidney",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40803758/",
        "source_type": "Global"
    },
    {
        "pmid": "40803408",
        "title": "Under Pressure: Identifying Factors for Pediatric Patients with Severe Traumatic Brain Injury Who Benefit from External Ventricular Drainage.",
        "abstract": "role external ventricular drainage EVD management pediatric traumatic brain injury TBI evolving discrepancy existing guideline clinical practice Recently EVDs associated better discharge disposition intracranial pressure ICP monitoring alone Using large national database sought identify patient benefited EVD placement retrospective cohort study child 16 years severe blunt TBI GCS 8 categorized incapacitated received EVD within 48 hour admission identified Trauma Quality Improvement Program TQIP 2016 2022  Injury severity type intracranial injury EVD procedure utilization center evaluated primary outcome discharge disposition Stratified competing risk survival model utilized multivariate analyses total 898 patient included mean age 844 years 194 death 216 univariate analysis Injury Severity Score ISS head Abbreviated Injury Severity Score AIS Glasgow Coma Scale GCS associated adverse discharge multivariate modeling ISS HR 404 p0001 cerebral edema HR 158 p0038 associated adverse discharge Epidural hematoma HR 021 p003 center EVD utilization HR 082 p0013 associated favorable discharge Patient factor injury severity score presence cerebral edema predictive mortality discharge hospice EVD placement Patients admitted higherutilization center EVD likely return home Level III",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40803408/",
        "source_type": "Global"
    },
    {
        "pmid": "40802019",
        "title": "Tricuspid Transcatheter Edge-to-Edge Repair (T-TEER): A Single Approach to a Multiforme Pathology.",
        "abstract": "review aim analyze current state transcatheter edgetoedge repair TTEER tricuspid regurgitation emphasizing patient phenotype enrolled major trial registries discussing potential pharmacological treatment strategy complex pathology Recent study highlighted significant impact tricuspid regurgitation morbidity mortality patient valvular heart disease heart failure pulmonary hypertension Advances multimodality imaging improved phenotyping TR TTEER trial registry demonstrated improvement TR severity quality life However mortality outcome remain neutral Novel therapy SGLT2 inhibitor show promise particularly patient concomitant HFpEF HFrEF ongoing trial broadening inclusion criterion better represent realworld populations TTEER represents promising interventional strategy managing tricuspid regurgitation yet challenge persist due heterogeneous nature disease difference trial realworld populations Optimizing patient selection integrating advanced imaging novel pharmacotherapies may enhance clinical outcome reduce hospitalizations paving way personalized treatment approaches",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40802019/",
        "source_type": "Global"
    },
    {
        "pmid": "40801823",
        "title": "The Synergistic Treatment of Heart and Kidney Disease.",
        "abstract": "incidence prevalence cardiac renal disease Germany steadily rising Heart disease common cause death especially among people chronic kidney disease Impaired kidney function increase risk cardiovascular events vice versa narrative review based pertinent publication retrieved literature search year 2025 particular attention guideline Association Scientific Medical Societies Germany Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften AWMF European Society Cardiology ESC Supplementary search conducted individual aspect epidemiology diagnosis treatment heart kidney disease heart kidney closely pathophysiologically linked damaged shared vascular risk factors including diabetes mellitus arterial hypertension chronic inflammation shared mechanism give rise continuum diseases Multiple RCTs shown recent year morbidity mortality patient heart kidney disease significantly lowered treatment ACE inhibitors also sodiumglucose cotransporter 2 SGLT2 inhibitors glucagonlike peptide 1 receptor agonist GLP1RA nonsteroidal mineralocorticoid receptor antagonist nsMRA Absolute risk reduction range 18 67 found achievable combined endpoint studied depending particular active substance used Heart kidney disease often arise together treated new pharmacotherapeutic strategies Open question remain concerning potential synergistic effect drug mentioned above suitable management polypharmacy enabling costeffective care",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40801823/",
        "source_type": "Global"
    },
    {
        "pmid": "40797194",
        "title": "The effect of health education on hypertension, diabetes mellitus, and cervical cancer screening service utilization among eligible adults in a district around Bahir Dar city, Ethiopia: a cluster randomized controlled community trial.",
        "abstract": "screening service utilization proven strategy early detection noncommunicable diseases populationbased health checkup service utilization low Ethiopia study aimed assess effect health education improving hypertension diabetes mellitus cervical cancer screening service utilization district around Bahir Dar City Ethiopia 2024 cluster randomized controlled community trial conducted district around Bahir Dar City among 214 adult intervention control group each intervention health education Trained parentteacher association member provided 30 min 1 h education community using existing social structures Adults control group continue receiving routine education health care system structured intervieweradministered questionnaire used collect data MacNemars test used assess intervention effect Binary logistic regression also used assess intervention effect controlling confounders Overall difference knowledge level adult intervention control group 344 P  0005 difference persists controlling potential confounders Respondents intervention group 22 time better knowledge noncommunicable disease compared respondent control group AOR  222 95 CI 14 34 overall difference utilization screening service targeted NCDs intervention control group 281 P  0001 difference persists potential confounders controlled Respondents intervention group 48 time likely utilize screening service compared respondent control group AOR  483 95 CI 27 85 Health education intervention parentteacher association member effective approach improve screening service utilization study suggests use parentteacher association member promote screening service utilization existing social structures trial registered Clinical Trialsgov NCT06639412",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40797194/",
        "source_type": "Global"
    },
    {
        "pmid": "40796325",
        "title": "Discordance and Shortcomings of Aldosterone Suppression Tests in Primary Aldosteronism.",
        "abstract": "saline suppression test SST captopril challenge test CCT traditionally used confirm exclude primary aldosteronism PA New guideline recommend using test predict likelihood unilateral PA study evaluated diagnostic accuracy consistency clinical implication tests conducted retrospective study 531 patient highprobability feature PA underwent SST CCT evaluate accuracy ability predict unilateral PA Adrenal lateralization surgical treatment decision guided individualized clinical judgment rather strictly relying SSTCCT results rate PA diagnosis ranged 478 972 based SST CCT criteria Discordance rate SST CCT ranged 109 516 analysis restricted patient clinically overt PA suppression testing considered necessary positivity rate SST CCT still suboptimal test discordance persisted Among patient lateralizing PA 66 279 either negative SST CCT interpretation among achieved PASOdefined biochemical cure unilateral adrenalectomy 41 398 either negative SST CCT 51 falsenegative result tests Wellestablished aldosterone suppression test PA demonstrated substantial inconsistency falsenegative interpretations inability reliably predict lateralization outcome PA Aldosterone suppression testing using SST CCT lack accuracy diagnosis subtyping PA highrisk patients",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40796325/",
        "source_type": "Global"
    },
    {
        "pmid": "40796251",
        "title": "Translating Guidelines, Protocols, and Care Pathways for Hypertension Into Effective Program Implementation.",
        "abstract": "Inconsistent terminology conceptual overlap among clinical practice guidelines treatment protocols care pathway lead confusion program design implementation Drawing implementation experience HEARTS Americasthe largest regional adaptation Global HEARTS Initiativethis communication describes characteristics functions interrelationship clinical practice guidelines treatment protocols care pathways outline respective role development approval execution clarify contribution health system organization clinical practice Clinical practice guideline composed evidencebased recommendation grounded rigorous scientific evaluation support clinical decisionmaking Care pathway serve implementation tool translate guideline standardized multidisciplinary plan organize hypertension management facilitate tasksharing engage patients Embedded within pathways treatment protocol offer simplified stepbystep approach tailored patients specifying limited set medication dosage ensure timely blood pressure control reduce therapeutic inertia promote consistent care delivery Clarifying distinction synergy among guidelines protocols care pathway might enhance alignment clinical guidance service delivery supporting effective implementation scaleup hypertension chronic disease management programs",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40796251/",
        "source_type": "Global"
    },
    {
        "pmid": "40795277",
        "title": "Health-Oriented Sleep States: Making Sleep States Reflect Health Conditions.",
        "abstract": "rich information sleep offer insight brain function overall health current guideline sleep staging American Academy Sleep Medicine AASM rely relatively broad categorizations traditional sleep stage optimized reflect health status Here propose healthoriented sleep state HOSS better associate preexisting health conditions observational retrospective cohort study involved 8673 participant Massachusetts General Hospital sleep laboratory examined seven preexisting conditions mild cognitive impairment MCI ischemic stroke atrial fibrillation myocardial infarction type2 diabetes hypertension depression clustered sleep staging models hidden layer within stage cluster represent sleep states number sleep state selected maximize average association health conditions using average area receiver operating characteristic curve AUROC across outcome based time spent states also assessed area precisionrecall curve AUPRC identified 3 state within N3 14 N2 6 N1 3 R 9 W AUROC ranged 0608 0723 across seven outcomes AUPRC 0064 0524 Among outcomes MCIdementia atrial fibrillation myocardial infarction hypertension demonstrated significantly stronger association health condition compared conventional AASM sleep stages Novel sleep state linked health conditions better understanding physiology behind sleep state may enhance concept using sleep window overall health",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40795277/",
        "source_type": "Global"
    },
    {
        "pmid": "40794599",
        "title": "International guidelines for the management of hypertensive disorders of pregnancy: an opportunity to improve the lifelong health of women?",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40794599/",
        "source_type": "Global"
    },
    {
        "pmid": "40794217",
        "title": "Renal Denervation for Hypertension: Current Evidence and Clinical Perspectives.",
        "abstract": "review summarizes current literature diagnosis treatment hypertension highlight persistent disparity care critically evaluates recent randomized controlled trial RCTs renal denervation RDN clarify emerging role hypertension management Despite decade therapeutic advances progress hypertension control plateaued significant undertreatment contributing ongoing cardiovascular disease particularly among woman minority populations Given limitation pharmacologic therapy alone growing interest alternative procedurebased strategies RDN using radiofrequency ultrasound modalities shown promise recent RCTs adjunctive treatment option Hypertension remains leading cause cardiovascular morbidity mortality persistently poor control rate highrisk group despite available therapies RDN demonstrated efficacy reducing blood pressure integrated clinical practice guidelines However longterm impact safety effectiveness diverse historically underrepresented population require study ensure equitable implementation",
        "mesh_terms": [
            "Humans",
            "Hypertension",
            "Kidney",
            "Sympathectomy",
            "Denervation",
            "Catheter Ablation",
            "Blood Pressure",
            "Randomized Controlled Trials as Topic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40794217/",
        "source_type": "Global"
    },
    {
        "pmid": "40794174",
        "title": "Reclassifying hypertension phenotypes in adolescents by ambulatory blood pressure monitoring: implications of the 2022 AHA guidelines in a Brazilian birth cohort.",
        "abstract": "Hypertension adolescent growing public health concern ambulatory blood pressure monitoring ABPM playing key role diagnosis 2022 American Heart Association AHA guideline introduced substantial change ABPM classification criteria exclusion blood pressure BP load criterion alignment diagnostic threshold adult values study aimed assess impact guideline revision prevalence hypertension phenotype among Brazilian adolescents conducted crosssectional study 1006 adolescent aged 1113 years BRISA cohort Ribeirão Preto Brazil Participants underwent 24h ABPM clinic BP cBP assessment Hypertension phenotype classified according 2014 2022 AHA guidelines Statistical analysis included prevalence comparisons reclassification patterns centroidbased phenotypic analysis prevalence cBP hypertension 34 Using either 2014 2022 AHA criteria around 13 adolescent classified hypertensive However 2014 guidelines nearly 20 cohort remained unclassified primarily due elevated BP load alone individual reclassified normotensive 2022 criteria leading 20 increase group One ten adolescent diagnosed masked hypertension Among hypertensive individuals half elevated nighttime BP only 2022 AHA guideline revision improved clarity hypertension classification prenatal cohort finding support clinical utility updated criterion highlight importance adapting ABPM interpretation current standards",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40794174/",
        "source_type": "Global"
    },
    {
        "pmid": "40793888",
        "title": "[Daily sodium intake determined in 24-hour urine in healthy adults and adults with comorbidities in Argentina].",
        "abstract": "wellestablished association sodium intake morbidity mortality Current international guideline recommend maximum daily sodium intake ranging 1500 2300 mgday Sodium measured 24hour urine collection considered gold standard estimating intake aim study assess daily sodium consumption compare across different populations crosssectional study including patient evaluated kidney stone KS candidate kidney donation KD Daily sodium intake estimated based 24hour urinary sodium excretion Adequate urine collection defined according estimated urinary creatinine total 214 subject included mean age 46 ± 14 years 60 female these 402 healthy adults 286 obese 168 hypertensive 28 diabetic 402 evaluated KS 598 KD mean sodium intake 3832 ± 1660 mg day Overall 958 exceeded 1500 mgday 846 exceeded 2300 mgday Similar result observed adequate urine collection n88 Men higher sodium intake women difference lost statistical significance adjusting height body surface area significant difference found among subgroup based comorbidities Sodium intake positively correlated weight height p0001 age body mass index blood pressure cohort sodium intake consistently exceeded international recommendations significant difference among subgroups Strategies urgently needed reduce sodium consumption prevent associated health risks",
        "mesh_terms": [
            "Humans",
            "Female",
            "Male",
            "Cross-Sectional Studies",
            "Argentina",
            "Middle Aged",
            "Adult",
            "Sodium, Dietary",
            "Comorbidity",
            "Hypertension",
            "Sodium",
            "Obesity"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40793888/",
        "source_type": "Global"
    },
    {
        "pmid": "40791946",
        "title": "Clinical characteristics, management approaches, and outcomes of patients with heart failure: the Jordan Heart Failure Registry.",
        "abstract": "Heart failure HF complex clinical syndrome diverse etiology pathophysiological mechanisms chronic HF gained substantial understanding acute HF remains less elucidated study aimed analyze data Jordanian Heart Failure Registry JoHFR assess clinical characteristics management approaches outcome patient HF study included data 21 healthcare center private sector clinic hospital public secondary tertiary university hospital across Jordan July 1 2021 February 28 2023 included patient age 18 chronic HF acute decompensated HF ide novoi acute top chronic HF Data encompassed patient demographics comorbidities medications clinical presentation laboratory findings echocardiograms outcomes total 2151 patient enrolled half 580 study cohort males mean age patient 66 years almost half patient 455 aged 70 older Chronic HF accounted 71 cases acute HF constituted 29 cases Obesity identified 366 cohort Hypertension 807 history atherosclerotic cardiovascular disease ASCVD 806 prevalent comorbidities Betablockers commonly prescribed medication 674 RAAS inhibitor including ACE inhibitor 181 ARBs 252 ARNI 108 also frequently used Dyspnea 859 common presenting symptom elevated Btype natriuretic peptide level well utilized observed patient 967 Left ventricular ejection fraction LVEF ≤40 588 4149 114 ≥50 297 patients mean SD 381 127 inhospital mortality rate registry stood 96 Jordan Heart Failure Registry JoHFR present unique characteristic chronic acute HF patient Jordan highlight area improving patient care adherence international guidelines finding guide healthcare policymakers practitioner country enhance quality management HF patient implement intervention reduce burden comorbidities accompanying HF",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40791946/",
        "source_type": "Global"
    },
    {
        "pmid": "40791889",
        "title": "Clinician underprescription of and patient nonadherence to clinical practice guideline-recommended medications for peripheral artery disease: a systematic review and meta-analysis.",
        "abstract": "Guidelines recommend adult peripheral artery disease PAD take antiplatelets statins antihypertensives However unclear frequently clinician prescribe medication ie underprescription often patient fail fillrefill prescription ie nonadherence factor increase underprescriptionnonadherence risk whether underprescriptionnonadherence associated outcomes searched MEDLINE EMBASE CENTRAL EvidenceBased Medicine Reviews January 1 2006toFebruary 18th 2025 study reporting cumulative incidencespoint prevalence clinician underprescription andor patient nonadherence antiplatelets statins andor antihypertensives adjustedrisk factor underprescriptionnonadherence adjustedoutcomes associated underprescriptionnonadherence among adult PAD Two investigator independently screened citations extracted data assessed risk bias Data pooled using randomeffects models Estimate certainty communicated using GRADE study registered PROSPERO CRD42022362801 Among 4206 citation identified 125 study n  14681801 participants 37 female included pooled cumulative incidence antiplatelet statin antihypertensive among PAD hypertension underprescription 28 95 confidence interval CI  2136 moderatecertainty 34 95 CI  3138 highcertainty 43 95 CI  3353 moderatecertainty respectively cumulative incidence antiplatelet statin antihypertensive nonadherence 27 95 CI  2035 moderatecertainty 28 95 CI  2433 highcertainty 23 95 CI  2224 lowcertainty respectively Underprescription common populationbased study enrolling female pastcurrent smoker nonadherence common study enrolling patient diabetes Underprescription risk factor included female sex advanced age malignancy history chronic limbthreatening ischemia all moderatecertainty Nonadherence risk factor included advanced age comorbidity burden receiving specialist mental health care all moderatecertainty Underprescription associated increased major adverse cardiac events allcause mortality decreased amputationfree time all moderatecertainty Onequartertoonehalf adult PAD prescribed antiplatelets statins antihypertensives Further approximately onequarter patient adhere medication prescription research supported 2024 Vanier Canada Graduate Scholarship awarded AMK supervised DJR Graham Farquharson Physician Services Incorporated Knowledge Translation Fellowship awarded DJR Research Program Award University OttawaDepartment Surgery Annual Competition awarded DJR",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40791889/",
        "source_type": "Global"
    },
    {
        "pmid": "40790764",
        "title": "The mitochondrial hub gene UCHL1 May serve as a potential biomarker for diagnosing diabetic cardiomyopathy: a comprehensive integration of biological pathways.",
        "abstract": "Diabetic cardiomyopathy DCM complex clinical syndrome characterized cardiac systolic diastolic dysfunction Research underlying mechanism mitochondrial dysfunction involved gene patient DCM limited aimed explore hub gene pathway related mitochondrial dysfunction affect progression DCM DCM patient datasets GSE161052 GSE210611 test sets GSE26887 validation set downloaded Gene Expression Omnibus GEO database identification differentially expressed gene DEGs performed using limma R package Mitochondrial dysfunctionrelated gene MDRGs associated DCM obtained Molecular Signatures Database MSigDB Gene Ontology GO Kyoto Encyclopedia Genes Genomes KEGG pathway analysis carried analyse biological function mitochondrial dysfunctionrelated differentially expressed gene MDRDEGs via ClusterProfiler DOSE orgHsegdb circlize R packages diagnostic value hub gene DCM confirmed using receiver operating characteristic ROC curve test validation groups Moreover function hub gene context DCM explored via gene set enrichment analysis GSEA protein‒protein interaction PPI network hub gene constructed using GeneMANIA database Finally realtime reverse transcription polymerase chain reaction realtime RT PCR analysis western blot analysis performed detect expression level UCHL1 total 705 DEGs 122 MDRGs closely related DCM identified 6 MDRDEGs AGT KIT SLC2A1 SLC2A4 TK2 UCHL1 obtained subjected GO KEGG enrichment analyses ROC curve analysis performed test validation groups AUC UCHL1 reached 10 test validation groups UCHL1 identified hub gene DCM GSEA revealed multiple biological pathway activated inhibited along alteration expression UCHL1 PPI network analysis revealed hub gene interacted mainly ASPSCR1 PTPRU STXBP3 SOCS6 UCHL5 proteins reciprocal regulatory relationship UCHL1 expression hsamiR181a5p hsamiR193b3p hsamiR8775p hsamiR2185p levels Finally realtime RT PCR western blot analysis revealed UCHL1 may used potential diagnostic biomarker DCM study 6 mitochondrial dysfunctionrelated hub gene related DCM identified mitochondrial hub gene UCHL1 demonstrated potential diagnostic biomarker DCM",
        "mesh_terms": [
            "Humans",
            "Diabetic Cardiomyopathies",
            "Biomarkers",
            "Ubiquitin Thiolesterase",
            "Protein Interaction Maps",
            "Gene Regulatory Networks",
            "Gene Expression Profiling",
            "Mitochondria",
            "Signal Transduction",
            "Gene Ontology",
            "Databases, Genetic",
            "Computational Biology",
            "ROC Curve"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40790764/",
        "source_type": "Global"
    },
    {
        "pmid": "40790553",
        "title": "Exploring the Link-Hiatal Hernia Repair and GERD Treatments for Managing Arrhythmias: A Systematic Review.",
        "abstract": "BackgroundGastrocardiac syndrome condition digestive issues particularly upper gastrointestinal tract linked heartrelated symptoms Gastroesophageal reflux disease GERD hiatal hernia HH notable causes release cytokine near damaged esophagus may promote atrial fibrillation AF Hiatal hernia may lead anatomical block arrhythmias systematic review aim investigate relationship treatment GERDHH improvementresolution arrhythmiasMethodsA systematic literature search conducted following PRISMA guidelines Databases including PubMed Embase Scopus searched January 2005 February 2024 using specific terms Two coauthors screened reviewed records Exclusion criterion included case without posttreatment information conference abstracts study type discussing relationship GERD HH arrhythmia included Data patient characteristics arrhythmia types treatments outcome extracted Murad checklist utilized quality assessmentResults13 study review included 11 case reports 1 case series 1 pilot study Hiatal hernia repair HHR proton pump inhibitor PPIs resolved arrhythmia case report case series Proton pump inhibitor treatment reflux esophagitis reduced AF symptom pilot study Arrhythmia resolution usually occurred shortly treatment began Patients mostly around 5962 year old males Hypertension esophagitis common comorbidities Paroxysmal atrial fibrillation PAF frequent arrhythmia type Antiarrhythmic medication stopped cases anticoagulation variedConclusionHiatal hernia GERD may contribute arrhythmias early management surgery PPIs show promise resolving symptom reducing medication reliance",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40790553/",
        "source_type": "Global"
    },
    {
        "pmid": "40790100",
        "title": "Clinical characteristics, mid-term outcomes and management of asymptomatic primary hyperparathyroidism: A multicentre retrospective cohort study.",
        "abstract": "primary objective study retrospectively evaluate demographic biochemical clinical characteristic patient asymptomatic primary hyperparathyroidism aPHPT analyze longterm outcomes discus effectiveness current therapeutic strategy light existing literature anticipate study provide clinician guidance regarding surgical decisionmaking beyond standard criterion aPHPT nationwide multicenter observational retrospective cohort study tertiary care endocrinology department across country invited participate Center inclusion criterion required enrollment sufficient number aPHPT patients confirmed careful diagnostic evaluation accordance established guidelines regular followup least one year systematic monitoring complications Data 27 center representing various region Turkey included study total 829 patient record reviewed excluding 25 patient meet eligibility criteria 804 patient included final analysis mean age 5559 ± 1154 years female predominance 85 n  683 baseline prevalence comorbidities follows hypertension 43 n  346 diabetes mellitus 271 n  216 cardiovascular disease 108 n  87 patients Bone mineral density BMD measurement available 701 patients among osteoporosis present 234 osteopenia 505 Glomerular filtration rate GFR significantly declined third year compared baseline p  0003 prevalence cardiovascular disease significantly increased year three compared baseline first year p  0002 significant association found presence osteoporosis lower baseline serum magnesium level p  0001 particularly among patient magnesium level 16 mgdL compared level within normal range 1625 mgdL Additionally patient osteoporosis demonstrated significantly lower serum phosphate level compared group p  0001 management asymptomatic PHPT continues present numerous unanswered questions Hypertension cardiovascular disease diabetes mellitus found prevalent among aPHPT patient compared general population observed increase cardiovascular event time suggests cardiovascular disease could become prominent factor future surgical decisionmaking Furthermore significant decline GFR followup may necessitate revisiting surgical threshold GFR  60 mLmin future guidelines Routine assessment serum magnesium phosphate level considered particularly patient high risk osteoporosis Future research may redefine surgical indication management aPHPT",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40790100/",
        "source_type": "Global"
    },
    {
        "pmid": "40790093",
        "title": "Targeting a systolic blood pressure of <130 mmHg is beneficial in adults with hypertension aged ≥75 years: a systematic review and meta-analysis.",
        "abstract": "Recent clinical trial raised important question regarding optimal blood pressure BP target older adult hypertension 2019 Japanese Society Hypertension guidelines systolic BP SBP target 140 mmHg recommended individual aged ≥75 years However subsequent randomized controlled trial RCTs shown potential cardiovascular mortality benefit associated strict BP targets conducted updated systematic review metaanalysis evaluate efficacy safety intensive SBP control 130 mmHg compared less intensive control ≥130 mmHg patient hypertension aged ≥75 years searched MEDLINE Cochrane Library Ichushi Web publication May 30 2024 supplemented manual searches Seven RCTs met predefined eligibility criterion included final metaanalysis Among patient aged ≥75 years intensive SBP lowering associated significantly reduced risk composite cardiovascular event risk ratio RR 061 95 confidence interval CI 040094 p  003 allcause mortality RR 072 95 CI 056093 p  001 cardiovascular mortality RR 055 95 CI 035088 p  001 increase serious adverse event RR 100 95 CI 093108 p  097 Stroke incidence differ significantly groups Similar result observed analysis expanded include study enrolled participant aged ≥70 years finding support safety clinical benefit targeting SBP 130 mmHg older adult hypertension",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40790093/",
        "source_type": "Global"
    },
    {
        "pmid": "40789986",
        "title": "Comparison of Clinical Characteristics in Older-Onset and Common-Age-of-Onset Gout: A Prospective Gout Cohort Study.",
        "abstract": "Gout inflammatory arthritis caused monosodium urate crystal deposition joints clinical presentation varies age onset study compared clinical feature treatment pattern olderonset gout commonageofonset gout analyzed data Urate Lowering TheRApy Gout registry Eligible participant aged ≥ 18 year met 2015 American College RheumatologyEuropean League Rheumatism classification criterion gout Olderonset gout defined gout diagnosed age 65 years commonageofonset gout gout diagnosed age 65 years Demographics clinical features treatment patterns quality life laboratory finding collected baseline 6 months Among 477 patients 105 220 olderonset gout 372 780 commonageofonset gout olderonset group included woman 257 versus 24 P  0001 showed higher frequency radiographic goutrelated joint damage erosion 305 versus 196 P  0018 comorbidities eg hypertension cardiovascular disease chronic kidney disease malignancy glucocorticoid use flare prophylaxis contrast commonageofonset group higher body mass index BMI frequent flares unhealthier lifestyle habit eg smoking alcohol higher rate nonsteroidal antiinflammatory drug NSAID benzbromarone use Febuxostat frequently prescribed olderonset group 714 versus 589 P  0019 benzbromarone use common commonageofonset group 73 versus 0 P  0004 febuxostat dose lower olderonset group 6 months group showed similar followup adherence flare frequency healthcare utilization Olderonset gout commonageofonset gout distinct clinical characteristics particularly comorbidities lifestyle factors treatment patterns Gout management tailored basis age onset",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40789986/",
        "source_type": "Global"
    },
    {
        "pmid": "40789697",
        "title": "Trends in 25 years of antihypertensive agent utilization in Croatia - an alert for scientific community and healthcare providers.",
        "abstract": "Hypertension leading modifiable risk factor cardiovascular mortality worldwide study aimed evaluate 25year trend antihypertensive agent AHA utilization Croatia 2000 2024 conducted national populationbased analysis using IMS IQVIA pharmaceutical databases Drug utilization measured defined daily dos per 1000 inhabitant per day DDD1000day alongside trend financial expenditure prescribing patterns 2000 2024 total AHA utilization tripled increasing 14457 43913 DDD1000day Agents acting reninangiotensin system RAS prescribed class throughout period prescribing volume rising 335 largely driven increased utilization fixeddose combinations Class shift included growing uptake βblockers RAS inhibitors alongside relative decline calcium channel blocker diuretics Total national expenditure AHAs increased €5362 million 2000 €9661 million 2024 reflecting evolving market dynamic sustained decrease average drug price per DDD change related broader access AHAs expanding role combination therapy regimen completely parallel introduction updated international guidelines Nevertheless demographic pressures clinical inertia policyrelated barrier continue constrain optimal blood pressure control finding highlight importance aligning national prescribing practice clinical evidence health system reform improve longterm cardiokidneymetabolic outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40789697/",
        "source_type": "Global"
    },
    {
        "pmid": "40786251",
        "title": "A Gamified Cardiometabolic Health Curriculum Utilizing a Student Response System for Internal Medicine Residents.",
        "abstract": "Cardiovascular disease frequently addressed primary care professional association guideline dictating standard care frequently change Teaching clinical practice guideline resident remains important promote knowledge retention subsequent implementation patient care Gamification utilizes social element technology promote accessible active learning enhances learner confidence engagement knowledge Data assessing gamification teaching guidelinebased care remains limited evaluated gamified cardiometabolic health curriculum utilizing student response system SRS assess benefit gamification teaching guideline internal medicine residents Methods developed gamified cardiometabolic health curriculum categorical resident internal medicine utilizing KAHOOT® Oslo Norway KAHOOT® SRS learner utilize mobile device answer questions Speed accuracy contributed placement digital leaderboard curriculum consisted one academic halfday five 45minute virtual didactics reviewing guidelinebased management type 2 diabetes mellitus T2DM hypertension hyperlipidemia metabolicassociated fatty liver dysfunction MAFLD weight management KAHOOT® selected promote ease participation gamified format compared traditional slidebased format Residents randomly assigned one five clinic groups Three group received gamified format two received traditional format without crossover Residents invited complete anonymous pre postsurveys collected quantitative data Likert scale rating confidence satisfaction learning test performance resident 108 108 received curriculum Around 59 64 received gamified format 44 41 received traditional format Prepost survey compared via matched analysis Anonymous survey matched via code provided resident resident completed one two survey excluded Likert scale rating confidence management increased hypertension hyperlipidemia MAFLD weight management T2DM likely T2DM lowest number matched resident pair analyzed Comparing gamified traditional formats difference postcurricular change absolute score boardstyle question increase Likert scale rating confidence majority resident 909 received gamified format found engaging minority 142 resident received traditional format found engaging Analysis limited low response rate 216 Anonymous prepost survey limited assessment nonresponse bias whether respondent characteristic differed nonrespondents gamified format similar traditional format increasing resident confidence managing cardiometabolic health condition knowledge guidelines gamified format felt engaging Although low response rate limit generalizability present initial data supporting efficacy virtual gamified curriculum utilizing SRS teach clinical practice guidelines Future avenue study include assessment longterm knowledge retention whether engagement translates increased learner participation",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40786251/",
        "source_type": "Global"
    },
    {
        "pmid": "40785651",
        "title": "Physical Activity, Sedentary Behavior, and Cardiometabolic Risk Factors in People Living with HIV.",
        "abstract": "Studies estimating association physical activity PA sedentary behavior SB cardiometabolic risk factor related condition among people living HIV PWH limited Data National Health Nutrition Examination Survey NHANES 200708 201718 cycles iNi  23810 includes 125 PWH representing 742174 PWH Adults classified based life epoch emerging 1829 yrs early 3044 yrs middle 4559 yrs adulthood Achieving aerobic iPA Guidelinesi ≥150 minwk moderatevigorous intensity PA MVPA quantified selfreport data collected across three domain transportation occupationhousehold leisuretime SB selfreported time sitting minday regardless domain Cardiometabolic condition included blood pressure body mass index BMI weight status hypertension chronic kidney disease Regression model estimated difference PA SB HIV status among PWH estimated association achieving iPA Guidelinesi cardiometabolic conditions also investigated whether age modified relation explored difference domainspecific PA across life epochs analysis indicate meeting iPA Guidelinesi resulted greater odds obesity higher diastolic blood pressure increase risk poor health among PWHan already highrisk group cardiovascular disease Future longitudinal study needed establish temporality",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40785651/",
        "source_type": "Global"
    },
    {
        "pmid": "40784689",
        "title": "Intrahepatic Portosystemic Shunt (TIPS): Evolving Indications.",
        "abstract": "Transjugular intrahepatic portosystemic shunt TIPS minimally invasive procedure used manage complication portal hypertension including frequently refractory ascites variceal bleeding TIPS established indications contraindications procedural guidelines scope expanding advancement technology improved evidencebased patient selection criteria article review current indication contraindication TIPS examines potential expanding applications discusses consensus guideline organization Society Interventional Radiology SIR Cardiovascular Interventional Radiological Society Europe CIRSE American Association Study Liver Diseases AASLD",
        "mesh_terms": [
            "Humans",
            "Portasystemic Shunt, Transjugular Intrahepatic",
            "Hypertension, Portal",
            "Patient Selection",
            "Treatment Outcome",
            "Risk Factors",
            "Radiography, Interventional",
            "Esophageal and Gastric Varices",
            "Gastrointestinal Hemorrhage",
            "Ascites"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40784689/",
        "source_type": "Global"
    },
    {
        "pmid": "40784656",
        "title": "Exploring Vascular Contributions to Cognitive Impairment: Small vessel disease of white matter and micro/nanoplastics.",
        "abstract": "Cognitive impairment due vascular pathology recognized Otto Binswanger 1894 Alois Alzheimer presented finding 1907 Vascular cause cognitive impairment likely due range pathology still hundred year later unknown Recent epidemiological evidence postmortem human brain report case may afflicted Alzheimers disease vascular disease both Although wellknown hypertension diabetes affect vasculature throughout body well brain type underlying cause primarily affect cerebral vessel understudied Consensus guideline exist histopathological diagnosis Alzheimers disease limited cerebrovascular diseases Here first anatomy brain vasculature reviewed Next schema categorization vascular pathology proposed followed example illustrate pathology together stain useful detection Scoring pathology across many case according schema subdivide vascular dementia underlying potentially treatable categories recent discovery micronanoplastics brain association vasculature profound influence vascularpathologyassociated cognitive impairment understood diagnosed Going forward anatomic pathologist need apply categorization triage type cerebrovascular pathology begin dissect underlying causes consequence potential treatments",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40784656/",
        "source_type": "Global"
    },
    {
        "pmid": "40784184",
        "title": "Systematic review and meta-analysis of the importance of pre-pregnancy maternal health on the risk of hypertensive disorders of pregnancy.",
        "abstract": "Stratifying woman using medical history prepregnancy may allow early identification woman highrisk Hypertensive disorder pregnancy HDP common highburden obstetrical complication would allow establishment early preventative approaches however research pregestational condition come data taken pregnancy address gap conducted systematic review metaanalysis adhering PRISMA MOOSE guidelines review comprehensively examined impact broad range medical disorder exclusively diagnosed prepregnancy development HDP including preeclampsia gestational hypertension superimposed preeclampsia eclampsia HELLP searched Medline OvidSP Embase OvidSP database inception 8th May 2021 calculated relative risk ratios adjusted study quality percentage incidences 4068724 study included qualitative research 177 classified quantitative assessment HDP risk increased pregestational renal condition 776 CI 5621071 hypertension 368 CI 151897 diabetes 357 CI 271470 high body mass index 265 CI 233303 well pregestational polycystic ovarian syndrome 190 CI 146248 rheumatoid arthritis 154 CI 142167 migraine 153 CI 132178 anxietydepression 152 CI 116200 Pregestational antiphospholipid syndrome systemic lupus erythematosus Takayasu arteritis also increased incidence gestational hypertension 8  7  17  preeclampsia 37  17  23  Overall review show prepregnancy maternal health help stratify HDP risk highlight importance oftenoverlooked risk factor current national guideline assessment tools Crucially provide evidencebased graphical abstractlist identified pregestational risk factor reference medical practitioner providing prepregnancy counselling",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40784184/",
        "source_type": "Global"
    },
    {
        "pmid": "40782829",
        "title": "Lipoprotein(a) in pregnancy: A systematic review and meta-analysis.",
        "abstract": "Pregnancy induces significant metabolic changes including altered lipid profiles yet role lipoproteina Lpa remains unclear Lpa level rise pregnancy may linked complication like preeclampsia gestational diabetes existing study show inconsistent findings metaanalysis aim investigate Lpa level normal highrisk pregnancy associated outcomes metaanalysis followed PRISMA guidelines systematically searching PubMed Scopus Web Science Embase study comparing Lpa level normal pregnant vs nonpregnant women highrisk vs normal pregnancies Data extraction quality assessment statistical analysis performed independently two reviewers Heterogeneity assessed using Isup2sup statistics sensitivity analysis GRADE evaluating evidence certainty Fortyone study included 31 metaanalyzed predominantly small crosssectional studies Compared nonpregnant women Lpa level modestly higher healthy pregnancy MD  502 mgdL p  001 lowcertainty evidence  GRADE woman preeclampsia Lpa level significantly elevated compared normotensive pregnancy MD  1192 mgdL 95  CI 768 1616 p  000001 lowcertainty evidence  GRADE Subgroup analysis demonstrated association consistent across different assay method also observed earlyonset ≤34 weeks MD  1291 mgdL lateonset 34 weeks MD  1060 mgdL preeclampsia significant difference observed woman gestational diabetes MD  885 mgdL p  039 lowcertainty GRADE metaanalysis found higher Lpa level pregnancy especially preeclampsia gestational diabetes finding suggest possible link Lpa hypertensive pregnancy complications study needed confirm clinical relevance establish predictive utility",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40782829/",
        "source_type": "Global"
    },
    {
        "pmid": "40781762",
        "title": "Cerebrospinal fluid and serum biomarkers in idiopathic intracranial hypertension: A systematic review.",
        "abstract": "study aimed systematically review literature soluble biomarkers adult idiopathic intracranial hypertension IIH Idiopathic intracranial hypertension multifactorial disorder marked elevated intracranial pressure without clear cause Although primarily affect overweight woman reproductive age pathogenesis remains incompletely understood Symptoms include headache visual disturbance due papilledema Increasing attention focused soluble biomarkers serum understand disease mechanism aid diagnosis management systematic review conducted accordance Preferred Reporting Items Systematic Reviews MetaAnalyses guideline registered PROSPERO CRD420250630653 systematic literature search conducted across PubMed Web Science Scopus study published English January 1995 December 2024 Articles investigating cerebrospinal fluid CSF andor blood biomarkers adult patient IIH included Multiple reviewer independently conducted screening data extraction quality assessment risk bias evaluated using ROBINSI tool total 38 study serumplasma urine CSF biomarkers met inclusion criteria identified biomarkers categorized five main groups 1 metabolicendocrine 2 systemic neurogenic inflammation 3 neurodegeneration 4 neural antibody CSF dynamics 5 miscellaneous Consistently elevated leptin level reported across studies alongside evidence cortisol dysregulation altered androgen profiles insulin resistance Inflammatory marker frequently elevated indicating state lowgrade systemic inflammation however finding regarding specific inflammatory marker variable lacked consistency Two study evaluated calcitonin generelated peptide CGRP plasma finding elevated level IIH especially migrainelike headache Neuronal marker like neurofilament light chain NfL increased correlated disease severity Emerging candidate included microRNAs metabolite identified metabolomic approaches novel protein discovered via proteomic analyses IIH appears involve interplay inflammatory metabolic neurodegenerative processes Although androgen dysregulation leptin NfL show consistent association substantial heterogeneity study method population limit generalizability CGRP may emerge promising biomarker reflecting predominant clinical symptomheadachepotentially guiding future therapeutic strategies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40781762/",
        "source_type": "Global"
    },
    {
        "pmid": "40781674",
        "title": "Association between the triglyceride-glucose index and symptomatic intracranial atherosclerotic stenosis in nondiabetic patients: a retrospective study.",
        "abstract": "investigate relationship triglycerideglucose TyG index symptomatic intracranial atherosclerotic stenosis sICAS nondiabetic patients retrospective study analyzed 968 nondiabetic acute ischemic stroke AIS patient admitted January 2022 December 2024 Intergroup difference sICAS group nonsICAS group analyzed TyG index calculated stratified TyG tertiles T1–T3 Multivariable logistic regression model adjusted age sex smoking status alcohol use hypertension status BMI lipid profile used assess association sICAS stenosis severity plaque vulnerability Restricted cubic spline explore nonlinear relationships Among 968 included patients median age 58 IQR 50–66 years 4339 male median TyG index 896 IQR 877 913 Patients sICAS presented significantly higher total cholesterol TC level TyG index values lower highdensity lipoprotein HDL levels highTyG group presented significantly greater prevalence male sex history smoking hypertension elevated body mass index BMI lower HDL levels elevated TyG index significantly associated sICAS moderate severe stenosis vulnerable plaques association maintained adjusting age sex smoking alcohol use hypertension BMI TC HDL lowdensity lipoprotein LDL levels Multivariableadjusted spline regression model revealed progressively increasing risk sICAS moderate severe stenosis vulnerable plaque related elevated TyG index elevated TyG index significantly associated sICAS independently associated severe intracranial arterial stenosis vulnerable plaque nondiabetic AIS patients",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40781674/",
        "source_type": "Global"
    },
    {
        "pmid": "40781664",
        "title": "Undiagnosed diabetes mellitus among older adults: a harmonized cross-country analysis of prevalence, regional disparities and risk factors in 11 European countries and Israel.",
        "abstract": "Undiagnosed diabetes mellitus uDM impact million people worldwide posing significant public health healthcare challenges Understanding sociodemographic health healthcare factor associated uDM essential reducing prevalence mitigating regional disparities enhancing early detection strategies Since early identification undiagnosed case ensures timely treatment slows progression complications save high cost healthcare systems survey focus people aged 50 year older Based data Survey Health Ageing Retirement Europe SHARE Wave 6 2015 11 European country Israel combine dried blood spot DBS result selfreported diabetes diagnosis identify uDM cases Harmonized blood spot collection analysis across SHARE country enhanced international comparability findings Weighted logistic regression applied study factor associated uDM compared normoglycemia pre diagnosed diabetes mellitus dDM prevalence uDM individual aged 50  SHARE country 2015 72 representing 342 diabetes cases Combined 140 dDM total prevalence diabetes 212 Mediterranean country showed higher uDM prevalence compared northern central European countries ranging 50 Denmark 148 Greece Compared people without diabetes undiagnosed individual lower socioeconomic status SES likely obese hypertensive yet selfrate health similarly without diabetes Compared people diagnosed diabetes undiagnosed share similar SES younger report fewer health problems generally selfrate health better Early detection diabetes underdeveloped Europe significant regional disparities Individuals uDM often underestimate risk due asymptomatic nature disease early stages highlighting need targeted public health intervention beyond typical risk groups result suggest diabetes awareness effective screening uDM still need increased particularly among younger seemingly healthy individuals lower SES obesity hypertension",
        "mesh_terms": [
            "Humans",
            "Israel",
            "Middle Aged",
            "Male",
            "Female",
            "Aged",
            "Europe",
            "Prevalence",
            "Risk Factors",
            "Diabetes Mellitus",
            "Health Status Disparities",
            "Undiagnosed Diseases",
            "Health Surveys",
            "Socioeconomic Factors"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40781664/",
        "source_type": "Global"
    },
    {
        "pmid": "40781583",
        "title": "3D IntelliGenes: AI/ML application using multi-omics data for biomarker discovery and disease prediction with multi-dimensional visualization.",
        "abstract": "cuttingedge artificial intelligence AI machine learning ML technique proven effective uncovering elucidative knowledge diseasecausing biomarkers biological underpinnings plethora human diseases However highdimensional nature multiomics data present numerous challenge effective presentation annotation interpretation Traditional 2D visualization often fall short capturing intricate relationship multiomics features hindering ability identify meaningful correlations study focused addressing challenge developing innovative solution better visualize result produced AIML approach integrated clinical multiomics data novel biomarker discovery predictive analysis present advanced version earlier published software intuitive interactive visualization multiomics data multidimensions ie 3D iIntelliGenesi offer deeper insights importantly capturing greater variability patient data understanding linear nonlinear structures evaluating AIML model performance delineating joint impact biomarkers corresponding disease states overall functionality 3D iIntelliGenesi divided two modules data clustering feature plotting data clustering module creates configurable 3D scatter plot visualize structurepreserving distribution disease states AIML classifier bias form type III errors patient similarity robust densitydriven clustering algorithm Whereas feature plotting module support joint analysis pair multiomics feature analyze interdependence discriminative power coexpressed biomarkers report evaluated performance 3D iIntelliGenesi using diverse cohort patient cardiovascular diseases",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40781583/",
        "source_type": "Global"
    },
    {
        "pmid": "40780449",
        "title": "Pharmacological Treatment Practices for Patients with Congenital Heart Disease and Pulmonary Hypertension in Japan: Insights from the Japanese Association of Congenital Heart Disease Registry (JACPHR).",
        "abstract": "Pulmonary hypertension PH serious complication impairs prognosis congenital heart disease CHD patients Japanese Association Congenital Heart Disease Pulmonary Hypertension Registry JACPHR nationwide CHDPH registry Japan established 2021 aimed clarify current status pharmacological treatment CHDPH using JACPHR data Data 266 registered CHDPH case JACPHR analyzed Patient characteristic revealed median age 116 year range 0785 years 511 systemic underlying diseases common Trisomy 21 278 Pharmacological treatment used 69 cases combination therapy 44 use combination therapy linked concurrent PH high pulmonary vascular resistance index Conversely patient left heart disease especially total anomalous pulmonary venous return less likely receive combination therapy Tadalafil macitentan commonly used medication age groups according agespecific analysis drug dosage pediatric patient either consistent guidelines recommended dos calculated using adult dosing recommendations conclusion combination therapy CHDPH widely used Japan including pediatric patients treatment decision based clinical context disease severity study shed light realworld application PHtargeted therapy CHDPH",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40780449/",
        "source_type": "Global"
    },
    {
        "pmid": "40780040",
        "title": "Dietary salicylates affect calcium and magnesium status in preeclampsia model rats induced by NG-nitro-L-arginine-methyl ester (L-NAME).",
        "abstract": "Preeclampsia PE represents complex hypertensive disorder pregnancy combine blood pressure elevation organ dysfunction mineral metabolism disturbances current guideline recommend lowdose aspirin PE prevention yet impact dietary salicylate mineral status remains open question research investigated dietary salicylate aspirin affect calcium magnesium homeostasis rat NGnitroLargininemethyl ester LNAMEinduced preeclampsia research involved pregnant Sprague Dawley rat received six different treatment groups CH healthy controls PE preeclamptic controls alongside four intervention group combined LNAME low high dietary salicylate LSP HSP aspirin LAP HAP preeclampsia model used LNAME 05 mgmL throughout gestational day 619 flame atomic absorption spectrometry method measured calcium magnesium level tissue serum samples highperformance liquid chromatography HPLC ultrahigh performance liquid chromatographytandem mass spectrometry system UHPLCMSMS analyzed salicylic acid concentrations administration LNAME resulted elevated blood pressure together elevated calcium level placental renal tissues tissue magnesium Mg level increased heart brain tissue animal consumed salicylate aspirin without effect blood pressure combination high salicylate intake resulted reduced calcium Ca level femoral tissue decreased albumin excretion urine CaMg molar ratio changed significantly kidney tissue well placenta tissue pancreas tissue preeclampsia condition caused LNAME disrupts normal distribution calcium magnesium throughout maternal fetal body tissues",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40780040/",
        "source_type": "Global"
    },
    {
        "pmid": "40779175",
        "title": "Long-term outcomes of ventriculoperitoneal shunt in HIV-negative Cryptococcal meningitis.",
        "abstract": "Cryptococcal meningitis CM lifethreatening fungal infection central nervous system intracranial hypertension major contributor mortality Ventriculoperitoneal VP shunting established crucial intervention managing elevated intracranial pressure however comprehensive longterm prognostic data CM patient undergoing VP shunt placement remain limited study aimed evaluate longterm outcome VP shunting patient CM retrospective analysis retrospective cohort study conducted involving patient diagnosed CM followup period 48 weeks Demographic characteristics diseaserelated parameters laboratory finding collected analyzed multiple time points 106 CM patient enrolled 77 underwent VP shunting 29 received conservative management significant difference observed two group term hospitalization duration cryptococcal clearance rate time cerebrospinal fluid CSF culture negativity recurrence rate VP shunt group demonstrated rapid reduction intracranial pressure ICP achieving normalization week 4 maintaining significantly lower level conservative group week 12 CSF cryptococcal count comparable group throughout followup period However VP shunt group exhibited persistently elevated CSF white blood cell WBC count protein level 48 weeks along transiently lower glucose level early stages normalized week 24 VP shunting effectively control intracranial hypertension accelerates cryptococcal clearance patient CM however significantly alter longterm clinical prognosis clinical significance postoperative CSF alteration may limited",
        "mesh_terms": [
            "Humans",
            "Ventriculoperitoneal Shunt",
            "Male",
            "Female",
            "Meningitis, Cryptococcal",
            "Retrospective Studies",
            "Middle Aged",
            "Adult",
            "Treatment Outcome",
            "Intracranial Hypertension",
            "Intracranial Pressure",
            "Aged",
            "Follow-Up Studies"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40779175/",
        "source_type": "Global"
    },
    {
        "pmid": "40779039",
        "title": "Correlation of cardiac risk factors with carotid and radial intima-media thickness measurements.",
        "abstract": "Early identification patient risk future cardiovascular event essential aim study evaluate relationship cardiovascular risk factor carotid intimamedia thickness CIMT radial intimamedia thickness RIMT prospective descriptive analytical study design used Two hundred fifty patient one modifiable risk factor underwent ultrasound measurement left right CIMT RIMT according standard guidelines Eightyone percent patient two risk factors Hypertension common modifiable risk factor 89 followed obesity 66 Male gender demonstrated significant increase mean CIMT ipi  005 Hypertension diabetes mellitus hypercholesterolaemia smoking contributed thickened mean CIMT odds ratio 399 282 247 209 respectively ipi  005 Combinations associated thicker mean CIMT included hypertension diabetes hypertension smoking odds ratio 692 367 respectively ipi  005 hypercholesterolaemia significantly associated thicker mean RIMT ipi  005 Male gender increased age hypertension diabetes hypercholesterolaemia smoking significantly contributed thickened CIMT whereas hypercholesterolaemia associated thickened RIMT Hypertension significant impact mean CIMT thickness Combinations risk factor appeared add summative risk thickened CIMT RIMT",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Carotid Intima-Media Thickness",
            "Middle Aged",
            "Prospective Studies",
            "Heart Disease Risk Factors",
            "Predictive Value of Tests",
            "Aged",
            "Adult",
            "Hypertension",
            "Radial Artery",
            "Smoking",
            "Carotid Artery Diseases",
            "Risk Assessment",
            "Sex Factors",
            "Hypercholesterolemia",
            "Carotid Arteries",
            "Risk Factors"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40779039/",
        "source_type": "Global"
    },
    {
        "pmid": "40778995",
        "title": "SETD2 drives METTL14-mediated m<sup>6</sup>A to suppress Piezo1 Attenuation and activate TGM2 to promote pulmonary hypertension.",
        "abstract": "Pulmonary arterial hypertension PAH characterized pathological vascular remodeling driven pulmonary artery smooth muscle cell PASMC proliferation METTL14mediated N6methyladenosine msup6supA RNA modification implicated PAH upstream regulator downstream effector linking msup6supA PASMC dysregulation remain unclear study investigates role SETD2 histone methyltransferase driving METTL14dependent msup6supA modification promote PAH via Piezo1 transglutaminase 2 TGM2 C57BL6 mouse subjected hypoxia pulmonary artery smooth muscle cell PASMCs periodically stretched establish PAH model vivo vitro epigenetic regulation METTL14 SETD2mediated H3K36me3 investigated chromatin immunoprecipitation ChIP Methylated RNA immunoprecipitation sequence MeRIPseq RNAseq dualluciferase reporter gene data used determine whether METTL14 enhances expression Piezo1 msup6supAdependent manner analyze comparison multiple datasets oneway ANOVA used METTL14 overexpression increased PASMC proliferation 145fold vs controls elevated global msup6supA level 173fold total RNA 143fold poly  RNA SETD2driven H3K36me3 histone modification upregulated METTL14 expression 176fold amplifying msup6supA deposition hypoxiainduced PAH mice METTL14 overexpression exacerbated hemodynamic severity increasing right ventricular systolic pressure RVSP 29 mean pulmonary arterial pressure mPAP 33 vs hypoxia alone SETD2 knockout PASMCs reduced RVSP 24 mPAP 28 pulmonary artery medium thickness PAMT 29 decreasing msup6supA level 48 Piezo1 mRNA stability increased 236fold via METTL14mediated msup6supA modification adenosine 1080 elevating Piezo1 protein expression 358fold PASMCs Piezo1 overexpression increased intracellular Ca²⁺ influx driving TGM2 activity 179fold restoring PASMC proliferation despite SETD2 deficiency study identifies novel SETD2H3K36me3METTL14msup6supA axis stabilizes Piezo1 mRNA promoting Ca²⁺dependent TGM2 activation PASMC proliferation PAH Targeting pathwayvia SETD2 METTL14 Piezo1 inhibitionmay offer therapeutic potential ameliorate vascular remodeling PAH",
        "mesh_terms": [
            "Animals",
            "Methyltransferases",
            "Transglutaminases",
            "Mice, Inbred C57BL",
            "Mice",
            "Myocytes, Smooth Muscle",
            "Histone-Lysine N-Methyltransferase",
            "Ion Channels",
            "Protein Glutamine gamma Glutamyltransferase 2",
            "Pulmonary Artery",
            "Adenosine",
            "Hypertension, Pulmonary",
            "Male",
            "Cell Proliferation",
            "GTP-Binding Proteins",
            "Vascular Remodeling"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40778995/",
        "source_type": "Global"
    },
    {
        "pmid": "40778148",
        "title": "A systematic review of behavioral interventions to improve maternal outcomes for women in the United States at high risk for adverse pregnancy outcomes.",
        "abstract": "Adverse pregnancy outcome APOs including hypertensive disorders gestational diabetes preterm birth affect 1020 US pregnancy substantially increase longterm cardiovascular disease CVD risk behavioral intervention pregnancy may reduce risk factor APOs evidence remains limited strategy effective highrisk women systematic review address gap examining pattern intervention design outcome reporting area research fails meet need atrisk pregnant populations searched PubMed Cochrane Central Register Controlled Trials article published January 1 2005 June 30 2024 Following PRISMA guidelines included USbased randomized controlled trial behavioral interventions diet physical activity sleep mindfulness selfmonitoring delivered pregnancy woman high risk APOs See Supplemental Figure S4 PRISMA Checklist Two reviewer independently performed screening data extraction riskofbias assessment using Cochrane Risk Bias Tool 3261 study screened 43 met inclusion criteria intervention focused individual prepregnancy overweight obesity often excluding CVD risk factors Thirtysix trial reported improvement outcome gestational weight gain GWG postpartum weight retention blood pressure biomarkers Interventions combining diet physical activity showed greatest benefit However four trial demonstrated improvement clinical outcome like gestational diabetes hypertensive disorders lipid profiles Outcome measure timeline varied widely trial included postpartum followup assessed outcome beyond GWG Although behavioral intervention pregnancy growing number trial limited heterogeneous designs narrow inclusion criteria inconsistent outcome reporting focus GWG exclusion woman complex risk profile reduce generalizability Inclusive research standardized outcome urgently needed improve maternal health reduce longterm CVD risk",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40778148/",
        "source_type": "Global"
    },
    {
        "pmid": "40777169",
        "title": "The relationship between carotenoids and diabetic nephropathy: insights from NHANES.",
        "abstract": "Diabetic nephropathy DN pose significant health risk imposes substantial global disease burden association carotenoid intake DN remains unclear Utilizing data 20072018 National Health Nutrition Examination Survey NHANES study investigates relationship multiple carotenoid subtypes DN aiming inform exploratory insight potential preventive strategies crosssectional analysis utilized NHANES 20072018 data multistage stratified sampling design fourstage screening process baseline participant selected excluding individual lacking diabetesrelated data pregnant women incomplete carotenoid intake DN diagnostic records Model 1 included 25483 participants Model 2 comprised retained 13271 participant adjustment covariates demographic characteristics lifestyle factors clinical indicators socioeconomic parameters Dietary intake six carotenoid subtypes iαcarotene βcarotene βcryptoxanthin Lycopene Lutein Zeaxanthini calculated using mean two standardized 24h dietary recalls Type 2 diabetes mellitus T2DM diagnosed based fasting plasma glucose ≥126 mgdL HbA1c ≥65 hypoglycemic medication use clinical diagnosis DN defined urinary albumintocreatinine ratio UACR ≥ 30 mgg estimated glomerular filtration rate eGFR  60 mLmin173 msup2sup T2DM patients Statistical analysis employed weighted multivariable logistic regression using R survey package adjusting sampling design covariates Associations quantified odds ratio ORs per 10 μgd carotenoid intake BenjaminiHochberg correction multiple comparisons significance threshold set iαi  005 NHANESbased study revealed nonlinear association dietary carotenoid diabetic nephropathy DN risk notable genderand ethnicityspecific genderethnicityspecific effects Univariate analysis demonstrated elevated DN risk higher βcryptoxanthin intake OR  1413 95 CI though significance attenuated dissipated multivariable adjustment suggesting confounding mediation obesity hypertension Multivariable model identified threshold effects low iαicarotene intake group exhibited 75 reduced risk OR  025 95 CI highintake group showed paradoxical risk elevation OR  224 95 CI βCarotene displayed genderdivergent effects highest tertile significantly reducing risk male 43 OR  057 95 CI Interaction model highlighted intensified iαicarotene protection male NonHispanic White OR  027029 whereas lycopene correlated fivefold increased DN risk NonHispanic Black OR  499 95 CI Cardinal risk factor included advanced age OR  106year obesity OR  107BMI unit male sex OR  305 hypertension OR  47 higher education OR  072 moderate alcohol consumption exerted inversely associated effects finding underscore necessity integrating nutrient threshold eg iαicarotene optimization social determinant DN prevention though racial subgroup analysis warrant validation prospective cohort due sample size constraints Clinicians managing DN should Prioritize Consider iαicarotenes biphasic doseresponse relationship prioritizing intake within optimal dosage window Utilize Leverage βcarotenes genderspecific benefit male patients Exercise caution consider exploringing lycopenerich dietary intervention diet African American populations Public health initiative incorporate nutrientgenderethnicity triadic assessment DN education program advance precision nutrition guidelines",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40777169/",
        "source_type": "Global"
    },
    {
        "pmid": "40776975",
        "title": "Metabolic Alterations Associated With Right Ventricular Dysfunction in Pulmonary Arterial Hypertension: The Modulatory Effects and Improvement Mechanisms of Exercise.",
        "abstract": "Pulmonary arterial hypertension PAH characterized significant increase pulmonary arterial pressure leading right ventricular failure RVF limited exercise capacity increased mortality risk Right ventricular function critical determinant exercise capacity prognosis patient PAH Meanwhile alteration cellular metabolism bioenergy common feature PAH differential regulation metabolic pathway playing significant role right ventricular dysfunction RVD Mitochondria essential organelle responsible energy production biosynthetic pathways signal transduction particularly implicated differential regulation Exercise increasingly recognized beneficial adjunct therapy however specific recommendation often lacking official guidelines review examines change metabolic pathway associated RVD PAH including glycolysis glucose oxidation fatty acid oxidation glutamine metabolism arginine metabolism Furthermore article discusses exercise modulate aforementioned metabolic pathway improve metabolic disturbance right ventricle enhance right heart function essential developing effective rehabilitation strategies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40776975/",
        "source_type": "Global"
    },
    {
        "pmid": "40776536",
        "title": "Theory-Based Interventions to Improve Medication Adherence Among Patients With Hypertension in Primary Healthcare and the Community: A Systematic Review.",
        "abstract": "Numerous intervention implemented enhance adherence antihypertensive medications yet utilized health behavioral theories research quality efficacy theorybased study remain undetermined systematic review aimed provide thorough description research employed health behavior theory improve medication adherence patient diagnosed hypertension particularly primary healthcare community settings PubMed Scopus searched randomized clinical trial employed health behavioral theory improve medication adherence patient hypertension published English 2013 2023 Data extracted following Preferred Reporting Items Systematic Reviews MetaAnalyses PRISMA guidelines Joanna Briggs Institute critical appraisal tool used evaluate risk bias 446 study initially identified 10 met inclusion criterion included systematic review Eight study employed single theory 2 applied combination theories Social Cognitive Theory Transtheoretical Model predominant Six trial demonstrated notable enhancement medication adherence 5 study assessed high risk bias Although study employed complete theoretical framework majority indicate utilizing theory enhance medication adherence",
        "mesh_terms": [
            "Humans",
            "Hypertension",
            "Primary Health Care",
            "Medication Adherence",
            "Antihypertensive Agents",
            "Health Behavior"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40776536/",
        "source_type": "Global"
    },
    {
        "pmid": "40776503",
        "title": "Effect of Altitude on Metabolic Syndrome.",
        "abstract": "Metabolic syndrome constellation overweightobesity hypertension disturbance lipid carbohydrate metabolism Hypoxic hypobaric condition high altitude alter use energy producing metabolic fuel may secondarily affect lipid blood glucose concentrations Thus study aim assess prevalence risk factor metabolic syndrome high low altitude inhabitant Nepal hospital based descriptive crosssectional study carried including 58 individual high altitude 58 individual low altitude attending Manmohan Memorial Teaching Hospital Kathmandu Anthropometric measurement blood pressure recorded blood sample obtained laboratory analysis sample analyzed fasting glucose triglycerides total cholesterol high density lipoprotein cholesterol low density lipoprotein cholesterol per standard guidelines Among study group 318 high altitude 682 low altitude found metabolic syndrome according National Cholesterol Education Program Adult Treatment PlanIII 355 high altitude 645 low altitude found metabolic syndrome according HJSS criteria prevalent defining component low high density lipoprotein cholesterol 388 high triglyceride 362 elevated fasting blood sugar 336 Hypertension 344 Among lifestyle factors alcohol consumption unhealthy diet physical inactivity found independent risk factor MetS High altitude inhabitant significantly lower metabolic syndrome low altitude inhabitant less physical activity work sedentary Thus encouragement food habit healthy lifestyle timely health screening monitoring help prevention metabolic syndrome",
        "mesh_terms": [
            "Humans",
            "Metabolic Syndrome",
            "Nepal",
            "Altitude",
            "Cross-Sectional Studies",
            "Male",
            "Female",
            "Adult",
            "Middle Aged",
            "Risk Factors",
            "Prevalence",
            "Life Style",
            "Blood Glucose",
            "Hypertension"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40776503/",
        "source_type": "Global"
    },
    {
        "pmid": "40776459",
        "title": "Impact Factors for Trajectories of Medication and Healthy Lifestyle Adherence in Young Adults With Hypertension: A Mixed Methods Study.",
        "abstract": "Treatment adherence cornerstone effective hypertension management However dynamic pattern adherence influencing factor among young Chinese adult hypertension remain insufficiently understood study aimed explore trajectory medication adherence healthy lifestyle behaviors well associated influencing factors population mixed method design employed First prospective cohort 89 young hypertensive patient established Adherence assessed using guidelinerecommended questionnaire 2018 Chinese Hypertension Guidelines 3rd 6th month followup Medication adherence categorized low moderate high healthy lifestyle adherence score encompassed six dimensions diet salt intake alcohol consumption smoking status physical activity weight control Second semistructured interview based Health Belief Model conducted identify factor influencing adherence Qualitative data coded accordingly followup 2807 participant exhibited decline medication adherence whereas 1930 showed improvement healthy lifestyle adherence 4607 declined 2247 improved Baseline characteristic differ significantly across different adherence trajectory group p  005 total 27 36 individual participated interview regarding medication lifestyle adherence yielding 553 878 codes respectively Social environmental patientrelated factor accounted 73 85 codes respectively frequently reported influencing factor included reminder encouragement family members childcare responsibilities occupational demands social obligations awareness hypertension conclusion young adult hypertension commonly experience fluctuation medication lifestyle adherence variation predominantly influenced combination social environmental individuallevel factors Trial Registration Chinese Clinical Trial Registry httpswwwchictrorgcn ChiCTR2000033434",
        "mesh_terms": [
            "Humans",
            "Hypertension",
            "Male",
            "Female",
            "Adult",
            "Healthy Lifestyle",
            "Prospective Studies",
            "China",
            "Antihypertensive Agents",
            "Surveys and Questionnaires",
            "Medication Adherence",
            "Young Adult",
            "Exercise"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40776459/",
        "source_type": "Global"
    },
    {
        "pmid": "40776427",
        "title": "Blood Pressure and Hypertension in Adolescents and Young Adults: Results From a Nationwide Screening Program.",
        "abstract": "Literature blood pressure BP norm adolescent young adult AYA population remains sparse compared adults study aim describe BP norms prevalence undiagnosed hypertension association demographic anthropometric data among asymptomatic Asian AYA males studied retrospective crosssectional data individual attending national centralized BP screening program enlistment 30 months individuals initial office BP reading used determine cohorts BP norms Individuals high reading defined systolic ≥140 mmHg andor diastolic ≥90 mmHg repeated office BP separate office visit demonstrating two high reading underwent 24h ambulatory BP ABP measurement 49 033 male median age 181 year studied median 75th centile 95th centile initial visit office BP reading 12174 13081 13989 mmHg 302 062 95 CI 055069 diagnosed hypertension office BP criteria 270 underwent ABP measurement180 037 95 CI 031042 239 049 95 CI 043055 hypertension ESCESH ACCAHA criteria respectively Higher weight body mass index BMI body fat percentage associated hypertension prevalence undiagnosed hypertension among Asian AYA male 1 Normbased cutoffs high BP yielded absolutevalue cutoffs similar recommended adult guidelines 95th centile corresponded closely 14090 mmHg Given similar diagnostic cutoffs normbased absolutevalue approaches method may adopted Focused screening subgroup higher risk hypertension obese individuals may considered resourcelimited settings",
        "mesh_terms": [
            "Humans",
            "Male",
            "Hypertension",
            "Adolescent",
            "Retrospective Studies",
            "Cross-Sectional Studies",
            "Young Adult",
            "Prevalence",
            "Blood Pressure",
            "Mass Screening",
            "Blood Pressure Determination",
            "Blood Pressure Monitoring, Ambulatory",
            "Adult",
            "Body Mass Index",
            "Female"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40776427/",
        "source_type": "Global"
    },
    {
        "pmid": "40775286",
        "title": "Healthcare providers perspectives on HIV-NCD integration to Meet the needs of older adults living with HIV.",
        "abstract": "Advances antiretroviral therapy enabled people living HIV PLHIV live longer healthier lives However aging HIV infection accompanied increased risk noncommunicable disease NCDs highlighting need integrate care services Academic Model Providing Access Healthcare AMPATH Eldoret Kenyahas providing care PLHIV 30 years seeing increase NCDs particularly hypertension diabetes especially among older patients unclear healthcare provider manage complex healthcare need older adult living HIV OALWH comorbid NCDs perceive integration hypertension diabetes care within HIV care platform conducted indepth interview AMPATH facility Eldoret Kenya Ten healthcare provider three nurse seven clinical officers interviewed explore facilitator barrier integrating HIV NCD care service OALWH Audio record transcribed verbatim content analysis performed capability C opportunity O motivation M model behavior change COMB model used comprehensively map driver barrier shape healthcare providers acceptance adoption implementation integrated HIV NCD care services majority participant worked five years offering care people living HIV participant experience managing older adult living HIV expressed challenge lack coordinated care delivery HIV NCDs participant highlighted potential challenge optimal adherence antiretroviral therapy ART among OALWH presence multiple chronic conditions Based challenges participant perceived integration hypertension diabetes care HIV care platform beneficial client overall healthcare system Factors availability physical resource infrastructure C availability training opportunity NCD care O leadership support M motivation provide personcentered care M perceived facilitator HIVNCD integrated care delivery Impeding factor lack guideline integration O siloed healthcare service delivery O inadequate resource allocation NCDs O perceived increased workload M also highlighted healthcare providers finding study highlight healthcare providers perceived facilitator barrier integration NCD care HIV care platforms insight gained study hold potential inform tailored interventions policy decisions capacitybuilding initiative aimed fostering successful integration improving overall health care delivery meet need OALWH resourceconstrained settings",
        "mesh_terms": [
            "Interviews as Topic",
            "Humans",
            "Kenya",
            "Attitude of Health Personnel",
            "Delivery of Health Care, Integrated",
            "HIV Infections",
            "Health Personnel",
            "Noncommunicable Diseases",
            "Capacity Building",
            "Health Services Needs and Demand",
            "Health Services for the Aged",
            "Qualitative Research",
            "Male",
            "Female",
            "Young Adult",
            "Adult",
            "Middle Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40775286/",
        "source_type": "Global"
    },
    {
        "pmid": "40775204",
        "title": "Value of serum-free light chain measurements in response and progression assessment in multiple myeloma with monoclonal protein measurable by electrophoresis.",
        "abstract": "Uniform assessment response treatment crucial managing multiple myeloma MM developing new therapies Measurement monoclonal protein form cornerstone disease assessment MM According International Myeloma Working Group IMWG guidelines serumfree light chain sFLC included MM response assessment patient measurable disease electrophoresis define stringent complete response retrospectively analyzed independent value serial FLC response progression assessment 839 patient measurable disease sFLC well serumurine electrophoresis significant association observed sFLC electrophoretic response initial therapy best response p  0001 study revealed comparable percentage change serial dFLC urine Mprotein parallel trend p  0001 strong correlation r 055079 p  0001 response detected earlier sFLC 11 months 95 CI 106117 sFLC ≥ PR two cycle induction demonstrated strong predictive value subsequent electrophoresis response OR 933 p  0001 Following induction difference PFS observed good partial response VGPR determined sFLC sPEP uPEP p  0538 median secondPFS patient sFLCprogression disease PD similar urine Mprotein PD without sFLCPD HR 128 95 CI 077213 p 0334 However median overall survival first relapse significantly better patient sFLCPD HR 187 95 CI 107327 p 003 Among patient PD 12 sFLC detectable tumor marker time secondline therapy study support incorporation serial sFLC measurement monitoring response progression MM even patient electrophoretic measurable disease advocate replacing 24h urine serial sFLC response assessment",
        "mesh_terms": [
            "Humans",
            "Multiple Myeloma",
            "Immunoglobulin Light Chains",
            "Male",
            "Female",
            "Middle Aged",
            "Aged",
            "Disease Progression",
            "Retrospective Studies",
            "Aged, 80 and over",
            "Adult",
            "Electrophoresis",
            "Myeloma Proteins"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40775204/",
        "source_type": "Global"
    },
    {
        "pmid": "40773030",
        "title": "Subaortic membrane in adult patients: retrospective study of clinical characteristics, outcomes, and echocardiographic associations and review of literature.",
        "abstract": "study aim describe clinical characteristics outcomes echocardiographic association subaortic membrane adult patients providing insight multifactorial etiology implication management retrospective study involved identifying patient underwent Transthoracic Echocardiography TTE past 10 year June 2013 June 2023 due clinical suspicion subaortic membrane received confirmed diagnosis subaortic membrane either TTE alone subsequent Transesophageal Echocardiogram TEE demographic patients including age diagnosis sex medical comorbidities aortic mitral valve disease hypertension history arrhythmias coronary artery disease heart failure diabetes mellitus chronic kidney disease included Features TTE documented subsequent surgical intervention recorded specifically subaortic membrane resection valve repair total 22 case studied mean age cohort 581 ± 106 years Common comorbidities included hypertension 636 obesity 454 heart failure 318 Quantitatively left ventricular LV ejection fraction varied normal 59764 moderately decreased 438 mean ejection fraction 659 ± 80 Diastolic dysfunction present various grades Six patient one ICU hospitalization 273 one patient one ICU hospitalization 45 subaortic membrane 909 visualized TTE Two patient possible finding suggestive subaortic membrane confirmed TEE 222 91 patient relatively benign course three patient 136 undergone surgical interventions majority patient survived 1722 773 Subaortic membrane rare condition limited incidence prevalence management data largescale study necessary investigate compile data establish guideline treatment",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40773030/",
        "source_type": "Global"
    },
    {
        "pmid": "40772922",
        "title": "Comparative Effectiveness and Safety of Labetalol Versus Nifedipine for Treatment of Chronic Hypertension During Pregnancy.",
        "abstract": "Clinical guideline recommend treatment chronic hypertension pregnancy either labetalol nifedipine firstline medication study aimed compare effectiveness safety labetalol nifedipine treatment chronic hypertension pregnancy used target trial emulation approach compare new user labetalol new user nifedipine analyzed data US Merative™ MarketScan® Commercial Database insurance claim 20072022 pregnant individual chronic hypertension infants effectiveness outcome composite severe preeclampsiaeclampsia medically indicated preterm birth placental abruption stillbirth safety outcome infant born small gestational age estimated risk ratio RRs risk difference RDs 95 CIs adjusting confounding stabilized inverse probability treatment weights studied 6724 pregnant individual chronic hypertension initiated either labetalol n  5504 82 nifedipine n  1220 18 pregnancy effectiveness outcome occurred 42 labetalol group 44 nifedipine group adjusted RR 103 95 CI 096111 adjusted RD 135 per 100 birth 95 CI 176 445 safety outcome small gestational age occurred 13 labetalol group 12 nifedipine group adjusted RR 098 95 CI 082116 adjusted RD 026 per 100 birth 95 CI 233 181 study suggests labetalol nifedipine similar effectiveness safety treating chronic hypertension pregnancy",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40772922/",
        "source_type": "Global"
    },
    {
        "pmid": "40772200",
        "title": "Effectiveness and Safety of Switching to Fixed-Dose, Preservative-Free Tafluprost/Timolol in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: A Real-World Study in Taiwan.",
        "abstract": "Objective objective study evaluate effectiveness safety tolerability preservativefree fixeddose combination tafluprost 00015 timolol 05 PF tafluprosttimolol FC patient openangle glaucoma OAG ocular hypertension OHT Methodology realworld prospective noninterventional study conducted Taiwanese patient OAG OHT inadequate response intolerance topical prostaglandin analogue PGA monotherapy therefore switched PF tafluprosttimolol FC primary endpoint mean change intraocular pressure IOP baseline six month initiating treatment Changes clinical sign subjective symptom also evaluated adverse event AEs recorded Results total 49 patient enrolled 42 completed study mean ± SD IOP baseline 165 ± 35 mmHg significantly decreased 154 ± 34 mmHg six month absolute reduction 11 ± 26 mmHg p  0001 number patient tear breakup time 10 second increased significantly three 75 baseline 22 525 six month p  0001 However nonsignificant increase observed subjective symptoms Six treatmentrelated AEs reported nonserious mild moderate severity including contact dermatitis redness itchiness blurred vision Conclusions realworld prospective study Taiwan demonstrated switching patient OAG OHT PGA monotherapy PF tafluprosttimolol FC effective safe reducing IOP",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40772200/",
        "source_type": "Global"
    },
    {
        "pmid": "40771833",
        "title": "Hypertensive Disorders in Pregnancy (HDP): Diagnostics and Therapy. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/018, June 2024).",
        "abstract": "bAimb S2k guideline German Society Gynecology Obstetrics DGGG contains consensusbased recommendation care treatment woman hypertension pregnancy aim serve guide profession involved care pregnant woman improve interprofessional interdisciplinary cooperation new focus placed patients longterm health beyond postpartum period bMethodsb existing S2k guideline revised relevant literature reviewed new question arose formulated developed PICO format targeted systematic literature search carried using PubMed international guideline also consulted summarizing presenting available data recommendation statement developed discussed agreed guideline group bRecommendationsb recommendation cover prediction prevention diagnosis treatment moment hypertensive disease detected pregnancy well postpartum puerperium breastfeeding major change previous version guideline reduction blood pressure level achieved pregnancy Suggestions made proceed regard longterm health mother child guideline group belief currently regulated inadequately German healthcare system",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40771833/",
        "source_type": "Global"
    },
    {
        "pmid": "40770599",
        "title": "Membrane-Associated RING-CH-Type Finger 6 Protects against Hypertension-Induced Cardiac Remodeling by Suppressing Cardiomyocyte Ferroptosis Through the Degradation of ACSL4.",
        "abstract": "Hypertension serf major contributing factor various cardiovascular disorders including heart failure Ferroptosisinduced cardiomyocyte loss recognized novel contributor myocardial remodeling heart failure Membraneassociated RINGCHtype finger 6 Marchf6 newly identified gene regulates ferroptosis implicated various disease processes However role Marchf6 modulating cardiomyocyte ferroptosis impact hypertensioninduced myocardial remodeling remain unexplored study aimed investigate whether Marchf6 influence myocardial remodeling regulation ferroptosis explore underlying molecular mechanisms finding indicated decrease Marchf6 level animal cellular model established Angiotensin II Ang II stimulation Overexpression Marchf6 conferred resistance Erastininduced ferroptosis Marchf6 knockdown increased sensitivity ferroptosis Ang II cellular model Marchf6 overexpression enhanced cell viability inhibited cardiomyocyte hypertrophy reversed ferroptosisrelated indicators whereas Marchf6 knockdown exhibited opposite effects Animal model study indicated Marchf6 overexpression significantly improved cardiac function alleviated myocardial hypertrophy fibrosis suppressed ferroptotic death levels Mechanistic investigation revealed Marchf6 significantly regulated stability ACSL4 protein Marchf6 overexpression accelerating ACSL4 protein degradation cardiomyocytes overexpressing Marchf6 ACSL4 overexpression notably reversed regulatory impact Marchf6 cardiac cell hypertrophy ferroptosis triggered Ang II Collectively finding suggest Marchf6 may mitigate cardiomyocyte ferroptosis promoting ACSL4 degradation thereby alleviating hypertensioninduced myocardial remodeling study uncovers novel regulatory mechanism cardiomyocyte ferroptosis myocardial remodeling also present viable target management hypertensionrelated cardiac diseases",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40770599/",
        "source_type": "Global"
    },
    {
        "pmid": "40770370",
        "title": "Lead-induced hypertension and cognitive dysfunction: brain amyloid pathology.",
        "abstract": "Lead Pb exposure recognized environmental risk factor cognitive decline may aggravate Alzheimers disease AD pathology hypertensionrelated mechanisms However specific role mineralocorticoid receptor MR signaling process remains unclear study investigated whether Pbinduced hypertension exacerbates amyloid pathology via MR activation evaluated therapeutic effect amlodipine spironolactone AD mouse model APPSwDI transgenic mouse exposed Pb acetate 25 mgkgday 8 weeks without concurrent treatment amlodipine spironolactone Cognitive behavior blood pressure renal function neuroinflammation oxidative stress brain amyloid deposition assessed Pb exposure significantly increased systolic blood pressure impaired cognition elevated IL1β IL6 levels enhanced brain amyloid burden MR expression brain tissue upregulated following Pb exposure spironolactone amlodipine improved cognitive performance reduced neuroinflammation oxidative stress Spironolactone effectively suppressed MR expression amyloid deposition though group difference reach statistical significance Pb exacerbates ADlike pathology MRrelated hypertensive inflammatory mechanisms MR antagonism spironolactone offer greater neuroprotection calcium channel blockade context finding suggest targeting MR signaling may promising therapeutic strategy environmentally induced AD risk",
        "mesh_terms": [
            "Animals",
            "Mice",
            "Hypertension",
            "Brain",
            "Cognitive Dysfunction",
            "Mice, Transgenic",
            "Lead",
            "Spironolactone",
            "Oxidative Stress",
            "Alzheimer Disease",
            "Amlodipine",
            "Receptors, Mineralocorticoid",
            "Male",
            "Disease Models, Animal"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40770370/",
        "source_type": "Global"
    },
    {
        "pmid": "40769802",
        "title": "Effects of intensive blood pressure control on cardiovascular outcomes in patients with diabetes: A systematic review and meta-analysis.",
        "abstract": "Hypertension frequently coexists diabetes affecting twothirds diabetic patient significantly increasing cardiovascular CV risk blood pressure BP reduction offer substantial benefit population optimal systolic blood pressure SBP target remains controversial metaanalysis evaluates effect intensive SBP lowering 130 mmHg versus standard therapy 150 mmHg key CV outcome hypertensive patient diabetes systematic review metaanalysis adhered PRISMA guideline included randomized controlled trial RCTs assessing SBP target diabetic patients Electronic database searched December 2024 Hazard ratio HRs allcause mortality CV death heart failure HF stroke major adverse cardiovascular event MACE major coronary heart disease event pooled using randomeffects model Risk bias evaluated using Cochrane Risk Bias Tool Four RCTs involving 21169 patient included Intensive SBP control significantly reduced stroke HR 071 p  001 HF HR 069 p  002 CV death HR 076 p  004 MACE HR 082 p  00001 showed significant impact allcause mortality HR 090 p  024 major coronary heart disease event HR 093 p  016 Heterogeneity minimal across outcomes Intensive BP control reduces stroke HF CV death MACE hypertensive diabetic patients highlighting role CV risk management Future research explore subgroup effects",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40769802/",
        "source_type": "Global"
    },
    {
        "pmid": "40769593",
        "title": "Six-Minute Walk Testing: Performance, Properties, and Clinical Applications.",
        "abstract": "Field exercise testing especially 6min walk test 6MWT widely used assess functional exercise capacity patient chronic respiratory diseases 6MWT safe easy administer costeffective represents natural daily activity Despite established guidelines variability test performance exists impact interpretation results 6MWT reliable repeatable extensively studied condition like chronic obstructive pulmonary disease interstitial lung disease pulmonary hypertension Application disease contextdependent Emerging variation include shorter duration test telemetric versions may continue expand clinical utility accessibility",
        "mesh_terms": [
            "Humans",
            "Walk Test",
            "Exercise Tolerance",
            "Pulmonary Disease, Chronic Obstructive",
            "Exercise Test",
            "Hypertension, Pulmonary"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40769593/",
        "source_type": "Global"
    },
    {
        "pmid": "40769047",
        "title": "Surgical technique challenges in adult aortic coarctation patients: A case series.",
        "abstract": "Aortic coarctation CoA relatively rare adult patient often present nonspecific symptoms typically result either delayed recognition residual lesion following incomplete repair childhood concomitant cardiac abnormality commonly detected children adult patient often present isolated CoA complication resulting late diagnosis Untreated CoA lead significant longterm complications including refractory hypertension heart failure aortic aneurysm rupture present case series three adult patient CoA varying severity associated cardiac pathologies patient underwent different open surgical approach First 39yearold male presented recurrent CoA severe adhesions Second 48yearold male presented proximal descending CoA accompanied ascending aortic aneurysm severe aortic stenosis Third 25yearold male presented CoA severe aortic valve insufficiency patient diagnosed CoA via echocardiography underwent surgical procedures Managing adult CoA particularly combined cardiac pathologies pose significant surgical challenge due lack standardized guideline complex conditions Surgeons must make critical decision regarding order repairs selection suitable surgical approach ideal timing intervention ensure patient safety Surgical approach CoA individualized based complexity coarctation associated cardiac pathologies Surgical management CoA either adult neonate performed accurately effectively reduce morbidity longterm complications",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40769047/",
        "source_type": "Global"
    },
    {
        "pmid": "40767789",
        "title": "Heart Transplantation for Cardiac Amyloidosis: Mayo Clinic Consensus Statement.",
        "abstract": "Cardiac amyloidosis CA infiltrative cardiomyopathy secondary amyloid fibril deposition myocardium two precursor protein frequently infiltrate heart resulting cardiac amyloidosis immunoglobulin light chain AL transthyretin ATTR Regardless type amyloidosis cardiac involvement portends worse prognosis patient symptom advanced heart failure referred heart failure specialist evaluation management Given lack formalized guideline heart transplantation CA propose recommendation pretransplant evaluation posttransplant management within context best current evidence addition expert opinion",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40767789/",
        "source_type": "Global"
    },
    {
        "pmid": "40767741",
        "title": "Integrative and complementary healthcare practices for hypertension: a summary of recommended clinical guidelines.",
        "abstract": "Identifying main us integrative complementary healthcare practice ICPHPs managing systemic arterial hypertension adults Evidence summary eligibility criterion clinical guideline Grading Recommendations Assessment Development Evaluation system others addressed ICPHPs hypertension language date restrictions Medline Embase Scopus database consulted Appraisal Guidelines Research Evaluation II tool used risk bias assessment focusing methodological rigor result summarized narratively grouping recommendation outcome analyzing commonality difference included guidelines Eight clinical guideline included evidence summary selected 560 record initially identified common intervention meditation yoga breathing techniques tai chi mindfulness positive impact blood pressure stress control patients quality life guideline recommended practice hypertension control based moderate quality evidence strong recommendation result summary indicate HCPs effective safe strategy complementary management hypertension suggesting holistic less medicalized approach managing condition",
        "mesh_terms": [
            "Humans",
            "Hypertension",
            "Complementary Therapies",
            "Practice Guidelines as Topic",
            "Quality of Life",
            "Adult",
            "Integrative Medicine",
            "Yoga"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40767741/",
        "source_type": "Global"
    },
    {
        "pmid": "40767090",
        "title": "The fluid challenge for identification of pulmonary hypertension associated with left heart disease.",
        "abstract": "Left heart disease LHD commonest cause pulmonary hypertension PH differential diagnosis PH associated LHD PHLHD pulmonary arterial hypertension PAH may difficult PH associated LHD causally related chronically increased pulmonary artery wedge pressure PAWP However PAWP may falsely normal highnormal time diagnostic right heart catheterization Updated guideline stepbystep diagnosis PAH LHD leave nevertheless proportion patient PH diagnostic uncertainty patients several study shown PAWP 18 mmHg rapid infusion 500 ml saline associated high likelihood LHD Evidence accumulated patient PH cardiovascular risk factor highnormal PAWP LHD excluded fluid challenge Preliminary study suggest test may performed noninvasively combining Doppler echocardiography lung ultrasound showing respectively ratio transmitral flow E wave mitral annulus tissue velocity e Ee ≥12 ≥5 Blines fluid challenge place stepbystep diagnostic workup patient referred PH differential diagnosis PHLHD PAH",
        "mesh_terms": [
            "Humans",
            "Hypertension, Pulmonary",
            "Diagnosis, Differential",
            "Pulmonary Wedge Pressure",
            "Cardiac Catheterization",
            "Echocardiography, Doppler",
            "Ventricular Dysfunction, Left"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40767090/",
        "source_type": "Global"
    },
    {
        "pmid": "40765727",
        "title": "Mortality of malignant otitis externa: A prevalence meta-analysis.",
        "abstract": "Malignant otitis externa MOE aggressive infection external auditory canal underlying bony structure skull base Predominantly caused Pseudomonas treatment shifted surgical medical antimicrobial therapy primary although surgical intervention may still required review aim provide global prevalence mortality data MOE help institution establish treatment benchmarks systematic review metaanalysis followed Preferred Reporting Items Systematic Reviews PRISMA guidelines Searches completed Scopus PubMed Databases article MOE mortality published 1994 2022 Publications included data MOE mortality genders total 22 study involving 9633 patient diagnosed MOE analyzed gender distribution nearly equal 4819 501 male 4814 499 females patients age ranged 18 90 years mean age 703 years pooled period prevalence mortality due MOE estimated 18 95 confidence interval 630 highlighting significant mortality risk patient condition Heterogeneity across study high Isup2sup  99 ipi  0001 Additionally prevalence comorbidities significant 571 patient diabetic 51 hypertension notable comorbidities included chronic pulmonary disease 122 liver disease 72 malignancy 34 common microbiological cause Pseudomonas aeruginosa 30 followed Staphylococcus aureus 10 Surgical intervention performed 37 cases cranial nerve involvement reported 9 patients primarily affecting facial nerve 91 Morbidity related MOE found 152 sepsis complication 05 cases result underscore importance addressing comorbidities mortality risk managing MOE patients review highlight significant global mortality rate 18 patient MOE comorbidities like diabetes hypertension contributing worse outcomes Despite current treatment advancements mortality morbidity remain substantial stressing need early diagnosis targeted interventions improved management strategy enhance patient survival outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40765727/",
        "source_type": "Global"
    },
    {
        "pmid": "40765180",
        "title": "Choosing the right calcium channel blocker for patients with hypertension and proteinuric chronic kidney disease.",
        "abstract": "Arterial hypertension diabetes mellitus represent major modifiable risk factor occurrence cardiovascular disease development chronic kidney disease CKD progression CKD endstage renal disease ESRD view rising burden hypertension diabetes mellitus CKD global scale currently great need drug effectively prevent onset reverse slow progression CKD diverse patient populations last decades growing body evidence demonstrated calcium channel blocker CCBs exert cardioprotective nephroprotective actions present narrative review aimed specifically describe cardiorenal protective effect dihydropyridine CCBs particularly lercanidipine manidipine based available evidence nondihydropyridine CCBs verapamil diltiazem regard research topic also reviewed 2023 European Society Hypertension ESH Guidelines management arterial hypertension endorsed International Society Hypertension ISH European Renal Association ERA 2023 European Society Cardiology ESC Guidelines management cardiomyopathies Finally proposed practical criterion prescribing appropriate CCB among dihydropyridine CCBs nondihydropyridine CCBs patient hypertension proteinuric CKD with without diabetes different clinical settings",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40765180/",
        "source_type": "Global"
    },
    {
        "pmid": "40764399",
        "title": "Associations between cardiovascular health metrics in life's essential 8 and incident hypertension: The LIFE Study.",
        "abstract": "American Heart Associations Lifes Essential 8 set modifiable lifestyle habit risk factor used assess cardiovascular health CVH However little known potential impact nonideal status metric hypertension risk study aimed clarify association total number nonideal CVH metric incident hypertension Japanese population retrospective cohort study conducted using data 10 Japanese municipality participating LIFE Study identified National Health Insurance enrollee undergone health checkup April 2017 March 2018 Participants categorized 7 group 0 1 2 3 4 5 67 metrics based total number nonideal CVH metric excluding blood pressure hazard ratio group reference 0 metrics newonset hypertension estimated using Cox proportional hazard models mean followup period 1405 days 22 826 245 participant developed hypertension Hypertension risk significantly increased higher number nonideal CVH metric hazard ratio ranged 1067 1 metric 1609 67 metrics Additionally nonideal CVH metric except blood lipid found significant predictor hypertension Higher number nonideal CVH metric Lifes Essential 8 consistently associated higher incidence hypertension Multicomponent lifestyle modification strategy improve overall CVH status may help prevent hypertension",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40764399/",
        "source_type": "Global"
    },
    {
        "pmid": "40763817",
        "title": "Impact of a structured educational intervention on attitudes and practice of heart failure in Latin America.",
        "abstract": "implementation heart failure HF guideline actual practice rarely adequate patient receive optimal treatments aim assess change attitudes knowledge confidence care pathway HF patient among physician Argentina structured educational intervention Crosssectional survey 22 public private health center physician participated comprehensive multimodule educational program patient identification classificationtherapeutic option advanced HF structureorganization HF Day Hospital education patient different stagesscenarios education nursing staff management patient different stagesscenarios Simple evidencebased roadmaps created address knowledge gaps intervention improved physicians confidence diagnosis HF preserved ejection fraction p  0001 prioritization quadruple therapy outpatient p  001 patient acute HF p  0001 proportion confidentvery confident physician identifying HF patient reduced ejection fraction could benefit implantable cardioverterdefibrillator increased significantly p  001 relevance hypertonic saline administration intravenous iron infusions use discharge checklist increased significantly intervention multifaceted structured intervention effective improving physicians confidence attitudes well knowledge care pathway HF patient Argentina",
        "mesh_terms": [
            "Humans",
            "Heart Failure",
            "Cross-Sectional Studies",
            "Male",
            "Female",
            "Argentina",
            "Attitude of Health Personnel",
            "Health Knowledge, Attitudes, Practice",
            "Middle Aged",
            "Adult",
            "Latin America"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40763817/",
        "source_type": "Global"
    },
    {
        "pmid": "40763750",
        "title": "[Management of Risk Factors and Comobordities in Atrial Fibrillation].",
        "abstract": "Atrial fibrillation AF common sustained arrhythmia gained increasing importance due demographic changes development AF multifactorial including nonmodifiable risk factor age genetic predisposition well modifiable factor like obesity alcohol consumption Common comorbidities include arterial hypertension heart failure sleep apnea syndrome diabetes mellitus Current study show treatment risk factor comorbidities prevents progression AF improves result rhythm control therapy Preventive measure weight reduction physical activity abstinence controlling cardiovascular risk factor important measure achieve predefined therapy goals German European AFguidelines advocate comprehensive treatment approach incorporating interdisciplinary strategy foster collaboration across multiple specialty effectively treat risk factor comorbidities",
        "mesh_terms": [
            "Humans",
            "Atrial Fibrillation",
            "Risk Factors",
            "Comorbidity",
            "Hypertension"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40763750/",
        "source_type": "Global"
    },
    {
        "pmid": "40762952",
        "title": "Estimation of age and sex-specific Glomerular Filtration Rate and its association with mortality and atherosclerotic cardiovascular outcomes in the Abu Dhabi population; A Retrospective Cohort Study.",
        "abstract": "impact reduced kidney function quantified estimated Glomerular Filtration Rate eGFR various adverse clinical outcome extensively studied study aim estimate age sexspecific eGFR Abu Dhabi population association adverse outcomes retrospective cohort study conducted 8699 participant enrolled national cardiovascular disease screening program 2011 2013 reference eGFR percentile estimated healthy cohort member comorbidities LMS Lambda Mu Sigma method used determine percentiles cohort reassessed 2023 mortality cardiovascular outcomes reference percentile normal eGFR value showed marked decrease age small sex difference reference percentile distribution Subjects two category within higher eGFR threshold range 95th 97th percentile older significantly higher prevalence diabetes frequently smokers higher body mass index higher HbA1c higher HDL lower vitamin D likely males higher physical activity lower prevalence coronary heart disease Older age female sex history atherosclerotic cardiovascular disease history hypertension treated hypertension lower diastolic blood pressure higher systolic blood pressure lower HDL higher HbA1c higher vitamin significantly associated lower eGFR percentiles ethnicityspecific eGFR reference value valuable early identification patient chronic kidney disease allowing early qualification beneficial preventive medication evaluations nephrologist referrals prognostic definition higher eGFR threshold renal hyperfiltration suggested since 97th percentile significantly higher incidence atherosclerotic cardiovascular disease",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40762952/",
        "source_type": "Global"
    },
    {
        "pmid": "40762058",
        "title": "Core Outcome Set for Studies on Cardiac Disease in Pregnancy (COSCarP): An International Delphi Consensus Study.",
        "abstract": "Outcome reporting cardioobstetrics study inconsistent objective COSCarP study Core Outcome Set Cardiac Diseases Pregnancy develop core outcome set international consensus harmonize outcome reporting cardioobstetrics studies conducted multimethod study February 2021 April 2023 included online 2round Delphi survey 3 small group discussion consensus meeting health service user people lived experience pregnancy heart disease health care professionals total 110 participant 22 health service user 88 health care professionals 13 country Africa Asia Europe North America scored 71 candidate item obtained literature review qualitative interviews Participants identified 12 core outcome 12 core reporting checklist item which may always represent outcomes inclusion cardioobstetrics studies Core outcome included maternal mortality cardiac arrest cerebrovascular events heart failure arrhythmia requiring treatment change treatment thromboembolism syncope maternal intensive care unit admission cardiovascular interventions perinatal loss miscarriage stillbirth neonatal death severe neonatal morbidity prolonged neonatal intensive care unit admission Reporting checklist item included hypertensive disorders major bleeding anesthetic complications adverse reactions labor birth details maternal hospitalization readmissions treatment compliance fetal growth restriction congenital malformations gestational age birth nonsevere neonatal morbidity Participants also identified 7 conditionspecific outcome 7 patientimportant outcomes may challenging measure study reported feasible relevant COSCarP study identified core outcomes reporting checklist items patientimportant outcomes researcher encouraged measure report future cardioobstetrics studies Widespread use COSCarP checklist could support data harmonization enable meaningful comparison studies facilitate metaanalyses ensure future guideline incorporate patientimportant outcome making clinical practice recommendations",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40762058/",
        "source_type": "Global"
    },
    {
        "pmid": "40760476",
        "title": "Performance of CAC-prob in predicting coronary artery calcium score: an external validation study in a high-CAC burden population.",
        "abstract": "Although CAC screening gaining recognition developing country Thailand official guideline using CAC score cardiovascular risk assessment remain lacking study aim externally validate CACprob recently developed prediction model estimate probability CAC  0 CAC ≥ 100 confirm robustness study externally validated CACprob model using retrospective data tertiary care centre northern Thailand Patients underwent CAC screening 2019 2022 included CACprob consists two models one predicting probability CAC  0 Model 1 another predicting probability CAC ≥ 100 Model 2 Model performance assessed term discrimination Ordinal Cindex calibration slope diagnostic index model total 329 patient included patient characteristic observed study indicated higher prevalence DM hypertension dyslipidaemia CKD CAC ≥ 100 compared development study ordinal Cindex derived validation study showed slight decline 078 calibration slope Model 1 Model 2 128 95 CI 095163 106 95 CI 078136 respectively Model 1 CACprob demonstrated comparable diagnostic performance However Model 2 showed slightly better performance significantly improved sensitivity compared development study external validation study confirms predictive performance CACprob Northern Thai patients finding support integration CACprob routine clinical practice aid physician making recommendation CAC screening",
        "mesh_terms": [
            "Humans",
            "Female",
            "Male",
            "Middle Aged",
            "Thailand",
            "Retrospective Studies",
            "Coronary Artery Disease",
            "Vascular Calcification",
            "Aged",
            "Risk Assessment",
            "Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40760476/",
        "source_type": "Global"
    },
    {
        "pmid": "40760432",
        "title": "Digital health tools for hypertension self-management: evaluating user experience and effectiveness in referral hospital in Imo state.",
        "abstract": "research aimed pinpoint user experiences factor influencing adoption digital health tool effectiveness tool hypertension selfmanagement study conducted selected referral hospital Imo State Nigeria descriptive study design conducted hospital setting three hundred thirty five 335 person serving respondents Data obtained use structured questionnaire analyzed using Statistical package Social Sciences SPSS version 270 software evaluate sociodemographic characteristics user experience effectiveness digital health tools factor influencing adoption success relationship sociodemographic variables study revealed diverse user demographics 10531 aged 3544 230 69 identifying Christians 170 51 belonging Igbo ethnicity respondent married 180 54 tertiary education 142 42 selfemployed 89 27 Despite high awareness 221 66 digital health tools challenge noted including dissatisfaction 74 33 difficulty user interface 62 28 accuracy issue 116 52 74 33 rated tool provide positive improvement 63 28 reported worsening blood pressure Factors influencing adoption included ease use 119 54 recommendation health provider 144 65 cost consideration 148 67 trust digital health technology 132 60 Significant association found socio demographic characteristic adoption factor age χ²  14067 p  0001 religion χ²  3495 p  0001 ethnicity χ²  771 p  0001 marital status χ²  4619 p  0001 number child χ²  16509 p  0001 educational level χ²  9973 p  0001 level income χ²  4663 p  0001 study shed light utilization digital health tool hypertension self management Addressing usability issues engaging healthcare providers improving affordability leveraging local support networks conducting longitudinal research recommended optimize effectiveness adoption digital health tool hypertension management region finding contribute growing body knowledge digital health intervention resourcelimited setting inform future research intervention aimed improving healthcare delivery outcome hypertension Nigeria similar contexts",
        "mesh_terms": [
            "Humans",
            "Nigeria",
            "Female",
            "Adult",
            "Male",
            "Hypertension",
            "Self-Management",
            "Middle Aged",
            "Surveys and Questionnaires",
            "Referral and Consultation",
            "Socioeconomic Factors",
            "Aged",
            "Digital Health"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40760432/",
        "source_type": "Global"
    },
    {
        "pmid": "40760279",
        "title": "Gender-based differences among ST-elevation myocardial infarction patients in Egypt: secondary analysis from the ACCA-EAPCI ESC-STEMI registry.",
        "abstract": "Genderbased variation management prognosis STsegment elevation myocardial infarction STEMI documented globally female often experiencing worse outcome males However limited data available disparity Egypt research aim evaluate genderbased variation management shortterm finding STEMI patient Egypt study analyzed 1356 STEMI patients 250 1844 female Women significantly older men 617 ± 113 vs 559 ± 11 years p  0001 greater prevalence comorbidities comprising diabetes 628 vs 353 p  0001 hypertension 552 vs 33 p  0001 prior stroketransient ischemic attack 72 vs 33 p  001 Women experienced longer delay seeking care symptom onset first medical contact time 42 ± 61 vs 31 ± 37 h p  0001 tended show advanced heart failure Killip class IIIIV 128 vs 69 p  0005 Despite similar rate primary percutaneous coronary intervention utilization woman greater rate inhospital mortality 76 vs 40 p  001 Multivessel disease less common women greater prevalence right coronary artery involvement culprit lesion 329 vs 217 p  0002 Medication prescription rate discharge revealed woman received highintensity statin 932 vs 961 p  004 ticagrelor 36 vs 78 p  001 less commonly Egyptian woman STEMI exhibit significant delay presentation greater burden comorbidities worse inhospital outcome compared men",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40760279/",
        "source_type": "Global"
    },
    {
        "pmid": "40759940",
        "title": "Perioperative outcomes among older surgical patients with multimorbidity: a longitudinal study from Ethiopia.",
        "abstract": "Multimorbidity particularly prevalent among older patients represents growing global health challenge study investigates prevalence multimorbidity relationship perioperative outcome among older patient undergoing major surgery Ethiopia longitudinal study conducted tertiary teaching hospital Northwest Ethiopia June 01 2019 June 30 2021 consecutive older aged 50 patient underwent major surgery study period included primary outcome measure estimating prevalence multimorbidity Secondary outcome measure association multimorbidity 28day perioperative mortality length hospital stay bivariable multivariable modified Poisson regression used compute crude adjusted relative risks respectively along 95 confidence interval CIs assess strength association adjusting confounding covariates pvalue  005 used declare statistical significance 874 patient underwent major surgery 234 2677 patient one comorbidity 94 1076 patient multimorbidity Among geriatric patients 130 1487 hypertension 34 389 diabetes mellitus 29 332 cancer common multimorbidity combination hypertension diabetes 18 cases rate perioperative mortality higher patient multimorbidity compared either one comorbidity 3646 vs 3333 vs 2821 p  0001 risk perioperative mortality surgery among patient multimorbidity eight adjusted relative risk  807 95 CI239 2723 time higher comorbidity Multimorbidity older surgical patient common one ten older patient undergoing major surgery multimorbidity Multimorbidity increase risk mortality among older patient following major surgery recommend targeted management older surgical patient multimorbidity preoperative screening optimization surgery",
        "mesh_terms": [
            "Humans",
            "Ethiopia",
            "Longitudinal Studies",
            "Female",
            "Male",
            "Multimorbidity",
            "Aged",
            "Middle Aged",
            "Length of Stay",
            "Aged, 80 and over",
            "Surgical Procedures, Operative",
            "Prevalence",
            "Perioperative Period"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40759940/",
        "source_type": "Global"
    },
    {
        "pmid": "40759931",
        "title": "Partial proportional odds model for predicting multiple lower extremity amputation among T2DM patients.",
        "abstract": "Multiple Lower extremity amputation MLEA unfortunate outcome following lower extremity amputation LEA individual diabetes challenge faced individual MLEA significantly higher undergone single amputation Therefore developing reliable accurate method determining risk factor associated MLEA essential reducing incidence outcome among diabetic patients study aimed explore demographic clinical characteristic diabetic inpatient foot ulcers goal develop statistical model determine risk factor MLEA among patient type 2 diabetic mellitus T2DM Data statistical model development collected patients folder involving 1972 patient T2DM hospitalized acute diabetic foot ulcer DFU three tertiary care hospital Fiji 2016 2019 crosssectional study conducted accordance STROBE guideline focusing patient experienced MLEA hospitals Patients categorized three ordinal outcomes noamputation primary amputation multiple amputations partial proportional odds model developed fit ordinal outcome determine risk factor associated MLEA proposed model validated comparing proportional odds model multinomial logistics regression model proposed partial proportional odds model PPOM identified several risk factor MLEA including age gender ethnicity hypertension anemia leukocytosis thrombocytosis analytical finding reveal PPOM appropriate determining risk factor associated MLEA T2DM patient Fiji",
        "mesh_terms": [
            "Humans",
            "Diabetes Mellitus, Type 2",
            "Male",
            "Amputation, Surgical",
            "Female",
            "Diabetic Foot",
            "Middle Aged",
            "Aged",
            "Cross-Sectional Studies",
            "Lower Extremity",
            "Risk Factors",
            "Models, Statistical"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40759931/",
        "source_type": "Global"
    },
    {
        "pmid": "40758790",
        "title": "Exercise as Medicine across the Autism Spectrum: A Conceptualized Framework.",
        "abstract": "prevalence autism spectrum disorder 1 31 child United States associated increased risk obesity diabetes hypertension shorter life expectancy benefit exercise individual autism spectrum disorder shown beneficial federal endorsed guideline exercise prescription FITT principle Frequency Intensity Time Type fail account complexity diversity autistic population present article address applicability traditional exercise prescription autistic individual present new conceptualized personal recommendation based current data available lived experiences evidencebased teaching strategies",
        "mesh_terms": [
            "Child",
            "Humans",
            "Autism Spectrum Disorder",
            "Exercise",
            "Exercise Therapy"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40758790/",
        "source_type": "Global"
    }
]